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Each year 15-20 infants with sickle cell disease and 600 infants with trait are born in western 
Pennsylvania with no significant decrease in annual incidence.  A 2006 study by Children’s 
Hospital of Pittsburgh’s Comprehensive Hemoglobinopathy Program surveying African-
American women in the prenatal setting found that these women have a high perception of the 
severity of sickle cell disease and the importance of sickle cell trait screening but a low perceived 
susceptibility to sickle cell disease.  The current research was designed as a qualitative follow-up 
study to assess African-American community members’ attitudes and knowledge of sickle cell, 
prenatal testing, and newborn screening, to characterize barriers to education and awareness of 
newborn screening and sickle cell, and to determine if a community-based intervention could be 
developed to improve awareness of these topics.  Four focus groups were conducted with 35 
participants at the Kingsley Association in a predominantly African-American community of 
Pittsburgh.  Participants were recruited from the Healthy Black Family Project.  Transcripts were 
analyzed using thematic analysis and demographic information was compiled from a pre-
discussion survey.  Qualitative analysis has demonstrated that participants fall into one of three 
knowledge categories: the unaware, those with accurate but incomplete information, and those 
with misinformation.  Participants have an understanding of sickle cell disease course.  However, 
inheritance of sickle cell and the personal risk to have children or family members with the 
condition is not well understood.  Participants have knowledge of the methods and indications 
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for prenatal testing and value prenatal testing for the opportunities for choice and awareness.  
Risks of prenatal testing were identified as miscarriage as well as personal and family stress.  
Newborn screening was believed to be beneficial for preparation and treatment.  Barriers to 
education and awareness of sickle cell and newborn screening were classified as personal, 
familial, and societal.  The public health significance of this work is the identification of 
community members who are eager to decrease the prevalence of sickle cell in their community 
and the potential to design community discussion groups which address genetics topics and 
provide African-Americans with the tools to communicate with family and physicians about risk 
for sickle cell.   
 v 
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1.0  INTRODUCTION 
The Center for Minority Health at the University of Pittsburgh’s Graduate School of Public 
Health is devoted to eliminating racial and ethnic health care disparities in the Pittsburgh area 
and to providing the tools for individuals to make informed decisions regarding both their own 
health and the health of their families.  Stephen B. Thomas, Director of the Center for Minority 
Health, along with a team of public health educators have established a mission based on the 
goals set forth by US Department of Health and Human Services Healthy People 2010 project: to 
eliminate ethnic and racial health disparities by the year 2010.  This mission has historically 
focused on seven core health issues including: cardiovascular disease, diabetes, hypertension, 
HIV and AIDS, infant mortality, immunizations, and mental health.  The Healthy Black Family 
Project is an extension of this mission with goals to reduce the rates of hypertension and diabetes 
in the African-American populations of Pittsburgh.  The project was established by the Center 
for Minority Health in 2003 and is housed within the Kingsley Center and Hosanna House of 
East Liberty and Wilkinsburg, respectively.  These primarily African-American Pittsburgh 
communities have been the focus of this intervention project but have also provided the energy 
to fuel a project which aims to help individuals change their lifestyle behaviors.   
Through the Healthy Black Family Project, a community based health intervention 
project, African-Americans living in the Pittsburgh area have the opportunity to participate in 
physical activity, smoking cessation, stress management, diabetes support group, and nutrition 
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classes at no charge.  Instructors provide not only the leadership for classes but also the 
motivation and positive reinforcement necessary to make these lifestyle changes.  Additionally, a 
team of genetic counseling students invite members to learn more about their family health 
history and the relationship between familial diseases and individual health through the Family 
Health History Initiative.  Members meet with a genetic counseling student to construct a three 
generation pedigree and then engage in a discussion about their individual health risks based on 
information gathered in the family health history.  At the conclusion of the family health history, 
an individual is invited to participate in the Minority Research Recruitment Database.  Informed 
consent allows the Center for Minority Health to contact the individual in the event future 
research studies become available and he/she would be eligible to participate.   
To date, three genetic counseling students have completed thesis projects analyzing the 
impact of the Family Health History Initiative.  Kristen Vogel examined the characteristics of 
individuals who complete the family health history and choose to participate in the Minority 
Research Recruitment Database (2005).  Results demonstrated that women and those without 
health insurance were more likely to enroll (Vogel, 2005).  Analysis was also able to identify the 
importance of incentives as motivation for participation in the database and distrust as the main 
barrier to enrollment (Vogel, 2005).  Research by Vinaya Murthy demonstrated that HBFP 
participants’ perceptions of colon cancer and heart disease risk were more likely to become 
accurate following the family health history session (2005).  This analysis identified the family 
history as a valuable tool in identifying at-risk individuals and promoting accurate risk 
perceptions (Murthy, 2005).  In addition to improving risk perception for chronic disease, the 
family health history was shown to increase self-reported physical activity of HBFP participants 
in research performed by Beth Dudley (2006).  These prior projects have illustrated the 
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effectiveness of the family history in increasing accuracy of health knowledge, changing lifestyle 
behaviors, and informing strategies for minority research recruitment.   
The overall goals of the Healthy Black Family Project have focused on health conditions 
and health issues where a racial or ethnic disparity is evident.  For example, epidemiological data 
on individuals residing in Allegheny County demonstrate that African-Americans are twice as 
likely to die from complications related to diabetes than Caucasians (Hunte, 2002).  The Healthy 
Black Family Project has developed a strategic plan to help prevent diabetes in those at risk and 
improve the health of those suffering with the condition through physical activity, dietary 
management, and the improvement of other lifestyle behaviors.  This targeted design has 
continued to make significant strides in lessening the impact of these common, multifactorial 
diseases among those residing in Pittsburgh communities.  However, there has been a significant 
lack of attention focused on alleviating the burden of sickle cell, a single gene disorder, in the 
African-American populations of Pittsburgh.  However, as the Healthy Black Family Project 
grows in its scope and ability to provide services, sickle cell disease will be a new opportunity 
where the project may target an intervention to decrease the burden of disease among African-
Americans residing in the Pittsburgh area. 
Through the aid of the Healthy Black Family Project and the Comprehensive 
Hemoglobinopathy Program of  Children’s Hospital of Pittsburgh, this project examined how the 
African-American community of Pittsburgh perceives sickle cell disease, sickle cell trait, 
individual and familial risk to pass on the condition, prenatal testing, and newborn screening.  In 
addition, this project attempted to address the community’s perceived barriers to education and 
awareness of sickle cell disease and newborn screening.   
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The Comprehensive Hemoglobinopathy Program of Children’s Hospital of Pittsburgh is 
responsible for following infants with abnormal hemoglobinopathy newborn screen results who 
reside in the 32 counties identified as Western Pennsylvania.  Within this region, newborn 
screening annually detects approximately 600 infants with sickle cell trait and 12-15 infants with 
sickle cell disease.  The majority of these children with sickle cell trait and disease are of 
African-American ethnicity, and despite the efforts of the Hemoglobinopathy Program, the level 
of sickle cell education and awareness in this community is not sufficient.  Information collected 
by the Hemoglobinopathy Program has demonstrated that a significant number of those families 
found to have a child with sickle cell trait do not elect genetic counseling through Children’s 
Hospital of Pittsburgh (Kladny, 2005).  Though a portion of these families may seek education 
elsewhere or receive genetic counseling via telephone, it is assumed that a majority do not 
receive the information necessary to understand the risks to future children and grandchildren to 
inherit sickle cell trait or disease (Kladny, 2005).   
A previous study by the Hemoglobinopathy Program of the University of Pittsburgh 
employed the use of surveys to assess the impact of sickle cell education on the acceptance of 
genetic screening for sickle cell trait in African-American women in the prenatal setting.  Results 
demonstrated that a brief educational intervention on sickle cell increases knowledge of sickle 
cell disease and the acceptance of carrier screening.  Survey results also showed that African-
American women of childbearing age have a high perception of the severity of sickle cell disease 
and the importance of sickle cell trait screening but a low perception of susceptibility to sickle 
cell disease and barriers to sickle cell trait screening.  At the conclusion of this work, 
recommendations were made to incorporate the results of this study into focus groups with 
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African-American community members in order to learn how to improve sickle cell education 
and awareness (Gustafson, 2006).   
The intent of this project was to accomplish the recommendations set-forth by this 
previous study, to provide insight into the attitudes and beliefs of Pittsburgh’s African-American 
population toward sickle cell disease, sickle cell trait, and newborn screening, and to offer 
potential strategies to improve the communication between health care providers and families on 
the inheritance and screening practices of this condition.  Future projects can use this information 
to develop community interventions where accurate information is disseminated, families are 
benefited, and the disease burden of this important genetic condition is significantly reduced.   
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2.0  SPECIFIC AIMS 
The specific aims of this study are as follows: To assess African-American community 
members’ 1.) knowledge and perceived risk of sickle cell 2.) attitudes toward and knowledge of 
prenatal testing 3.) attitudes toward and knowledge of newborn screening 4.) barriers to 
receiving information on newborn screening and sickle cell.  Additionally, this study will attempt 
to determine if a community-based intervention could be developed to improve communication 
about sickle cell and newborn screening. 
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3.0  BACKGROUND AND SIGNIFICANCE 
3.1 SICKLE CELL DISEASE 
Sickle cell disease is an autosomal recessive genetic condition that results in red blood cells with 
a characteristic sickle shape.  Individuals with this condition can experience hemolysis, anemia, 
pain episodes, swelling, and vascular occlusion potentially leading to ischemic attacks and organ 
damage (Richer, 2005; Wethers, 2000, “Part II”; Wilson, 2003).  Sickle cell disease is a pan-
ethnic condition with the highest prevalence among those of African, Mediterranean, Middle 
Eastern, Indian, Caribbean, and Central and South American descent (Wethers, 2000, “Part I”; 
Wilson et al, 2003).  Every 1 in 12 African-Americans is a carrier for sickle cell trait, and the 
disease affects every 1 in 375 African-Americans (Richer, 2005; Wethers, 2000, “Part I”). 
3.1.1 MOLECULAR GENETICS AND PATHOGENESIS 
Mutations in the HBB gene are responsible for causing the known forms of sickle cell disease 
including hemoglobin SS disease, hemoglobin SC disease, hemoglobin SD disease, and the two 
forms of sickle beta-thalassemia, HbSβ+ and HbSβ0 (Richer, 2005; Wethers, 2000, “Part I”; 
Wilson et al, 2003).  The HBB gene encodes the beta-globin chains of hemoglobin, an oxygen-
carrying protein composed of two alpha and two beta chain subunits found within red blood 
cells.  This type of hemoglobin is known as hemoglobin A.  Mutations in the HBB gene lead to 
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an altered beta-globin chain and resulting structural change to the protein conformation of 
hemoglobin.  In HbSS disease, a mutation in the sixth codon of exon 1 in the HBB gene is 
responsible for creating hemoglobin S.  This mutation results in the replacement of glutamic acid 
with valine in the amino acid chain.  Two of these HbS mutations are required to cause the 
phenotypic features of sickle cell disease (Ballas, 2002; Wilson et al, 2003).  HbSS disease 
represents 60-70% of all sickle cell anemia (Richer, 2005).  However, additional mutations 
responsible for HbC, HbD, or beta-thalassemia can also cause the features of sickle cell disease 
in the presence of an HbS mutation (Richer, 2005).   
The expressivity of clinical features in individuals with sickle cell disease is difficult to 
predict.  However, individuals with HbSS and HbSβ0 have the most severe disease expression 
(Wilson et al, 2003).  In comparison to HbSβ0, where there is a complete inability to produce a 
beta-globin chain, those individuals with HbSβ+ produce a smaller quantity of beta-globin chains 
and therefore, have a milder disease course (Wethers, 2000, “Part I”). 
Hemoglobin S and other abnormal beta-globin chains ultimately create a brittle 
consistency that is easily lysed but is also more capable of adhering to the endothelial cells of the 
vascular system.  The pathogenic process begins when the sickled hemoglobin is polymerized as 
a result of deoxygenation.  The red blood cell then becomes dehydrated and deformed (See 
Figure 1).  It is this red blood cell that can adhere to the vascular endothelium.  As this process 
occurs, cell signaling factors produced by platelets bridge the gap between receptors on the 
endothelium and the sickled red blood cell.  The adherence of sickled red blood cells to the 
endothelium has been shown to be responsible for the vaso-occlusion, pain crises, and strokes 
that can occur in individuals with sickle cell disease (Ballas, 2002; Wilson et al, 2003).   
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 Figure 1. Sickled Cell 
(Laird 2006) 
3.1.2 CLINICAL COURSE OF SICKLE CELL DISEASE  
The severity of the clinical course in sickle cell disease is variable among affected individuals 
(Wilson et al, 2003).  The onset of symptoms usually occurs within the first two years of life 
with a presentation of body pain and swelling of the hands and feet called dactylitis (Claster & 
Vichinsky, 2003).  The pain episodes of sickle cell disease can vary in frequency and severity.  
Beginning at a young age and continuing through adulthood, these pain episodes can prevent 
individuals from attending school and work and interfere with daily life (Claster & Vichinsky, 
2003).  Children and adults must be closely monitored for infection and sepsis.  Infection may be 
marked by pain, swelling, and fever (Claster & Vichinsky, 2003).  Even low-grade temperatures 
must be considered when evaluating an individual for infection (Claster & Vichinsky, 2003).  
These infections most often include Salmonella species and Staphylococcus aureus (Claster & 
Vichinsky, 2003).  Human parvovirus B19 infection is responsible for approximately 80% of 
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aplastic crises, when red blood cell production is significantly reduced in the bone marrow 
(Claster & Vichinsky, 2003). 
The hemolysis that occurs due to the sickled shape of blood cells can lead to chronic 
anemia, jaundice, and delays in growth while increased red blood cell adherence to the 
endothelium increases the likelihood of vaso-occlusion and organ damage.  Red blood cells can 
become trapped in the spleen causing decreased hemoglobin concentration and enlargement of 
the spleen (Claster & Vichinsky, 2003).  This process called splenic sequestration can increase 
damage to the splenic tissue and potential for infection (Claster & Vichinsky, 2003).  As sickled 
red blood cells accumulate in the endothelium of the cerebral arteries, there is a potential for 
brain injury (Claster & Vichinsky, 2003).  Strokes usually occur without warning but can also be 
preceded by headaches or loss of coordination (Claster & Vichinsky, 2003).  Approximately 
10% of children with sickle cell disease will experience a stroke before age 18 (Claster & 
Vichinsky, 2003).  Children between 4 and 6 years of age are at highest risk for stroke (Wethers, 
2000, “Part II”).  Vaso-occlusion can also cause damage to the genitourinary system.  Renal 
acidosis, damage to the distal renal tubule, renal medullary carcinoma, proteinuria, and renal 
failure may occur (Claster & Vichinsky, 2003; Wethers, 2000, “Part II”).  Males are at risk to 
experience vaso-occlusion in the form of priapism where obstruction of the venous drainage can 
cause a long-lasting and painful erection (Claster & Vichinsky, 2003; Wethers, 2000, “Part II”).   
Patients with sickle cell disease may experience acute chest syndrome, a condition 
characterized by fever, chest pain, and/or difficulty breathing.  The appearance of a new 
pulmonary infiltrate on radiological studies of the chest is evidence for a diagnosis of acute chest 
syndrome and can be caused by infection and/or infarction.  Both bacteria and viruses may be the 
infectious agents responsible.  However, the most common cause of acute chest syndrome is a fat 
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emboli from an infarction of the long bone which travels to the lung (Claster & Vichinsky, 2003; 
Wethers, 2000, “Part II”).   
Individuals with sickle cell disease have a shortened lifespan in comparison to their 
healthy counterparts.  However, cohort studies following children with sickle cell disease from 
birth to age 18 years have demonstrated an increase in the mean age at death and a decrease in 
childhood mortality.  Infection has been identified as the number one cause of death in sickle cell 
patients, but studies are demonstrating a decrease in mortality rates due to infection.  This 
increase in survival and decrease in mortality due to infection are attributed to early 
identification of disease through newborn screening and early intervention through prophylactic 
antibiotics (Quinn et al, 2004).   
3.1.3 INHERITANCE AND RECURRENCE RISK 
Sickle cell disease is inherited in an autosomal recessive manner (Richer, 2005).  In the majority 
of cases, affected individuals have parents who are obligate heterozygotes or carriers for sickle 
cell trait.  Individuals with sickle cell trait do not experience health effects as a result of their 
carrier status.  The parents of an affected child who are known carriers of sickle cell trait have a 
25% chance to have a second pregnancy with sickle cell disease, a 25% chance to have an 
unaffected child, and a 50% chance to have a child who is a carrier of sickle cell trait.  All 
children of an affected individual will inherit a sickle cell mutation from this parent.   
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3.1.4 DIAGNOSIS 
A sickle cell disease diagnosis can be achieved through hemoglobin electrophoresis, isoelectric 
focusing, high performance liquid chromatography, and/or molecular testing.  These tests have 
comparable accuracy, but isoelectric focusing and high performance liquid chromatography are 
the most common methods performed to achieve an initial diagnosis.  Automated isoelectric 
focusing provides a high degree of resolution when determining what types of hemoglobin are 
present.  Liquid chromatography is useful for separating out proteins even at low concentrations, 
but this technique is limited by its inability to detect HbSβ0 (Richer, 2005; Wethers, 2000, “Part 
I”). 
Solubility tests such as Sickledex should never be used in the diagnosis of sickle cell 
disease.  This test can identify the presence of sickled cells but is unable to determine which 
hemoglobin variants are present.  Newborns have inaccurate solubility test results due to the 
predominance of fetal hemoglobin present at birth.  Solubility testing has also been shown to be 
inaccurate in individuals with severe anemia (Wethers, 2000, “Part I”).   
Clinical molecular genetic testing is available for the HBB gene through targeted 
mutation analysis and sequencing (Richer, 2005).  A detection rate of approximately 99% is 
reported by laboratories providing testing.  Molecular testing can be used to confirm the 
diagnosis of sickle cell disease, test carriers, and perform prenatal diagnosis with a known 
mutation. 
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3.1.5 MANAGEMENT OF SICKLE CELL DISEASE 
Sickle cell disease requires a team of physicians for the management of clinical features.  For 
patients, pain is often the most difficult feature to manage because of the potential for 
physicians’ misperceptions regarding the cause of pain and fear of addiction to pain medication 
(Wethers, 2000, “Part II”).  Pain can be due to vaso-occlusion, acute chest syndrome, avascular 
necrosis, and other orthopedic problems (Claster & Vichinsky, 2003).  Pain crises often require 
hospitalization and IV narcotic pain medication.  Prophylactic hydroxyurea therapy has been 
shown to lessen the incidence and severity of pain episodes and incidence of acute chest 
syndrome in adults with sickle cell disease.  There is limited data on the use of this therapy in 
children.  Adequate hydration, oral analgesics, and avoidance of extreme heat and cold have 
been shown to alleviate the occurrence of pain crises.  Often a pain management plan is 
instituted to prevent delay in the control of pain when a patient seeks care at a hospital 
emergency room (Claster & Vichinsky, 2003; Wethers, 2000, “Part II”).  
 Prophylactic antibiotics should be started as soon as a diagnosis of sickle cell disease is 
established.  Preferably, this occurs as soon as possible after a positive newborn screening result.  
Providing prophylactic penicillin to infants has been shown to reduce mortality from 
pneumococcal sepsis.  Proper immunizations should be adhered to in a timely manner for these 
children.  The influenza vaccine is also strongly encouraged (Claster & Vichinsky, 2003; 
Wethers, 2000, “Part II”). 
Management guidelines are in place for acute chest syndrome, enlarged spleen, and 
stroke.  Sickle cell disease patients are often followed closely by pulmonology specialists for 
acute chest syndrome and pulmonary hypertension.  Treatment for acute chest syndrome may 
require antibiotics, pain medication, and oxygen.  Those individuals with pulmonary 
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hypertension can experience cardiac and respiratory complications.  Oxygen therapy, 
hydroxyurea treatment, vasodilation, and/or anti-coagulants may be beneficial to prevent 
progression of this condition where there is potential for sudden death.  An enlarged spleen can 
but does not have to follow an infection in sickle cell patients.  Treatment may include penicillin, 
transfusion, and/or splenectomy depending on the severity of the condition.  The strokes 
experienced by individuals with sickle cell can be both silent and catastrophic events.  Symptoms 
of headache, hemiparesis, seizures, or changes in coordination or personality may be indicative 
of a stroke.  Due to the high risk of a second stroke, these patients are most often put on a 
preventative transfusion protocol after confirmation of the initial stroke through MRI (Claster & 
Vichinsky, 2003; Wethers, 2000, “Part II”). 
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3.2 NEWBORN SCREENING 
3.2.1 HISTORY OF NEWBORN SCREENING 
Newborn screening is a specific panel of tests performed on a blood sample obtained from the 
newborn in the first few hours of life.  Newborn screening has a history beginning in the early 
1960s when Dr. Robert Guthrie developed a simple and effective test to screen newborns for 
phenylketonuria (Pass, 2000).  Phenylketonuria is a genetic disease caused by the body’s 
inability to metabolize the amino acid phenylalanine into tyrosine.  The essential enzyme 
phenylalanine hydroxylase is rendered non-functional due to mutations in the PAH gene.  When 
left untreated, phenylketonuria causes an accumulation of phenylalanine in the brain and 
ultimately, mental retardation.  The testing process implemented by Dr. Guthrie was designed to 
take a sample of blood from the infant’s heel which was then placed on a piece of filter paper 
(Pass, 2000).  The sample could be analyzed using bacterial inhibition techniques applied 
directly to the filter paper (Pass, 2000).  It was a fast, efficient, and sensitive method of 
determining if an infant was affected by phenylketonuria (Pass, 2000).  Positive results indicated 
the need to administer restrictive dietary therapy which could prevent accumulation of 
phenylalanine and stop the process leading to mental retardation (Pass, 2000). 
Newborn screening for phenylketonuria was eventually adopted by all states in order to 
attempt to eliminate this preventable form of mental retardation (Therrell, 2006).  Mandatory 
newborn screening programs required states to pay for laboratory fees and medical follow-up for 
those children with positive results (Therrell, 2006).  However, the screening program for 
phenylketonuria was believed to be cost-effective for states because it decreased the need to pay 
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for the institutionalization of individuals with mental retardation resulting from this genetic 
condition (Therrell, 2006).   
3.2.2 CURRENT STATUS OF NEWBORN SCREENING IN THE UNITED STATES 
In general, the newborn screening process can be broken down into five components: screening 
of the newborn, follow-up, diagnostic testing, disease management, and evaluation.  The 
screening of newborns begins with obtaining parental informed consent in some states and then a 
heel stick blood sample is spotted onto filter paper or Guthrie card.  This card is then sent to 
either a state sponsored or commercial lab where automated testing is typically performed.  In 
most states, follow-up is pursued only if the infant has a screening result which falls outside the 
normal range (See Figure 2).  Negative results are reported to the pediatrician and do not require 
the infant to be evaluated.  Follow-up of abnormal newborn screen results includes locating the 
infant and then contacting the family to inform them of the result.   
 
Figure 2. Follow-up Process for Newborn Screening Results (Pass, 2000) 
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Appointments are established with a newborn screening center or pediatrician within about two 
days following the result.  Upon evaluating the infant at this appointment, further diagnostic 
testing is often pursued.  Newborn screening provides indication of laboratory values outside the 
normal range but cannot always be diagnostic.  Further testing often includes DNA testing and/or 
more specialized laboratory tests.  Once a formal diagnosis has been established, the infant is 
typically followed by their pediatrician for management of the condition.  Management can 
include treatment, dietary and nutrition counseling, genetic counseling to discuss the inheritance 
and recurrence risk of the condition, and addressing the psychosocial needs of the family.  The 
newborn screening program must be continuously evaluated to ensure it is meeting the needs of 
the families who are affected by a positive diagnosis and that the child’s care is coordinated as 
he/she ages (Kaye, 2006; Pass, 2000). 
There is currently no federal law overseeing newborn screening in the United States 
which leads to a lack of standardization and consistency from state to state (Therrell, 2006).  The 
choice of which genetic conditions are screened for and how these screening programs are 
regulated is controlled by individual state legislation (Therrell, 2006).  Currently, all states screen 
for sickle cell disease and trait except New Hampshire where screening is required but has not 
been completely implemented (Kaye, 2006).  Only twenty states have regulations which include 
consent requirements and each of these states differs in what requirements parents must fulfill to 
opt in or out of screening (Therrell, 2006).  Additionally, only twenty states have regulations 
which require newborn screening program healthcare professionals to provide education to 
parents prior to the screening process (Therrell, 2006).  The method of parental education may be 
oral, written, or both, and the timing of education in some states can come well after the testing 
process has occurred (Therrell, 2006).  Fifty programs have developed a newborn screening 
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pamphlet which in the majority of cases describes how the blood sample will be obtained, what 
conditions are being screened for, and how results will be reported (Therrell, 2006).  Less than 
half of newborn screening program pamphlets discuss the possibility of a false-positive result, 
the limitations of testing, and when results will be available (Therrell, 2006).  Examination of the 
readability and user-friendliness of these newborn screening brochures has demonstrated that 
92% are written above an eighth grade reading level which has been established as the average 
reading level of a US adult (Arnold, 2006).  Additionally, 81% of brochures required 
improvement in helping parents to identify the essential information (Arnold, 2006).  A study 
surveying the 52 newborn screening programs in the United States and its territories regarding 
genetic counseling following a positive diagnostic test found that 76% of programs routinely 
offer counseling to families of affected infants (Farrell, 2001).  Even more striking, only about 
50% of programs offer genetic counseling after diagnostic testing reveals a false-positive 
newborn screen result or an infant is identified as a carrier (Farrell, 2001).   
The follow-up appointment for infants with an abnormal newborn screen result also lacks 
standardization in the information which is communicated to parents.  A 2005 study examining 
the content of communication between pediatric residents and parents following a newborn 
screen result for sickle cell trait demonstrated many missed opportunities by physicians to share 
key information.  This study analyzed conversations for key content regarding sickle cell disease 
and trait, early placement of good news regarding sickle cell trait in comparison to sickle cell 
disease, and the ratio of individualized to general information.  Results demonstrated that only 
8.5% of transcripts contained the key content thought to be necessary for parental understanding 
and only 27% provided reassuring news about sickle cell carrier status in relation to sickle cell 
disease.  Approximately 22% of physician statements were in regards to sickle cell disease which 
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the newborn did not have and 50% of transcripts included misinformation about the risk of 
sudden death in those with sickle cell trait (Farrell, 2005). 
There is evidence to suggest that general practitioners and pediatricians who manage 
abnormal newborn screen results do not feel competent in this role.  A randomized mailed survey 
of these physicians found that 89% of pediatricians and 44% of general practitioners had 
managed an abnormal newborn screen result within the past five years (Kemper, 2006).  
Approximately 56% of these physicians would prefer newborn screening centers to provide the 
initial evaluation of the infant and a majority of general practitioners stated that they did not feel 
competent discussing the conditions found on the newborn screening panel (Kemper, 2006).  
Interestingly, only 64% of pediatricians felt it was necessary to refer newborns with sickle cell 
trait for genetic counseling while 81% believed it was necessary to refer newborns who are 
carriers for cystic fibrosis (Kemper, 2006).  This could be explained by a lack of understanding 
regarding the autosomal recessive inheritance of both of these conditions.  In situations where an 
infant is a carrier for sickle cell or cystic fibrosis, it would be important to discuss parental 
carrier screening and the possibility of having a child affected with disease if both parents are 
found to be carriers.  These results also indicate pediatricians are unfamiliar with the ACTion 
sheets developed by the American College of Medical Genetics to provide a step by step process 
of how to manage an abnormal screening result for each condition on the panel (Kemper, 2006).  
Current ACTion sheets explicitly state that newborns with sickle cell trait should be offered 
genetic counseling (Kemper, 2006).   
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3.2.3 QUALITATIVE ANALYSIS OF PARENTAL UNDERSTANDING OF 
NEWBORN SCREENING 
A qualitative analysis of parental understanding of newborn screening and the informed consent 
process was conducted in the United Kingdom in 2005.  A total of 47 parents who had 
participated in the newborn screening program were interviewed over the telephone or attended a 
focus group.  Their responses were classified within three categories: information for parents, 
degree of parental choice, and recording parents’ decisions.  A majority of parents stated they did 
not recall receiving information about newborn screening before the blood sample was obtained 
but admitted that the time following the birth was chaotic.  The parent may not have been 
focusing on the informed consent process.  Parents also stated they did not feel there was an 
emphasis placed on the seriousness of the possible screening results during the communication 
exchange with a physician or nurse.  However, the majority opinion was that it is unnecessary to 
provide detailed information about the genetic conditions prior to the test results.  This 
information can overload a new parent and cause needless worry.  Participants felt newborn 
screening should be routine, and the process of informed consent would provide justification for 
screening and decrease the number of parental refusals.  Parents felt that verbal consent to 
screening was sufficient and written consent would increase the number of parental refusals 
(Hargreaves, 2005). 
A 2003 study conducted twelve focus groups including 102 participants to examine the 
attitudes, beliefs, and concerns of parents regarding newborn screening.  Participants included 
both Caucasian and African-American parents from in and around the Chicago, Illinois area.  
Specifically, seven focus groups were composed entirely of African-American participants.  
Focus group questioning centered on newborn screening for treatable (phenylketonuria) and 
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untreatable (Duchenne muscular dystrophy) conditions.  Researchers found very few individuals 
who could accurately describe newborn screening.  In four separate focus groups, there were 
zero participants who could describe newborn screening.  In each of three focus groups, one 
respondent was able to supply information regarding the type of conditions being screened for 
and the need to provide treatment.  Participants expressed confusion over the difference between 
newborn screening and the testing of infants for drugs, alcohol, jaundice, and infection.  
Importantly, only one individual out of 102 participants mentioned newborn screening as a 
method to test for sickle cell disease.  The majority of individuals felt newborn screening is 
beneficial and should be mandatory.  The opinion that young, unknowledgeable parents may 
refuse screening and ultimately hurt their children through late detection of disease appeared 
throughout conversations.  When asked to describe their concerns about newborn screening, 
participants were fearful that they would not be told the true purpose for which their child’s 
sample would be used.  Parents also expressed concern regarding using a child as a guinea pig 
and the government obtaining blood samples for cloning.  An overarching theme among 
participants was the need for parental education throughout the newborn screening process.  
Many parents supported the idea of providing this education during the prenatal period 
(Campbell, 2003). 
The newborn screening communication process was further explored in a 2006 
qualitative study of newborn screening knowledge and awareness among parents and health care 
providers.  This study recruited an ethnically diverse sample of 51 parents and 78 health care 
providers from Louisiana, New Mexico, and Maryland for 22 focus groups.  Approximately 43% 
of participants were African-American.  In support of previous studies, a majority of parents 
expressed a lack of knowledge about what newborn screening is and what it tests for.  This study 
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found similar confusion among parents about the difference between newborn screening and 
testing for environmental exposures.  Very few parents were aware of when and how they would 
be contacted about results of screening, and many did not know retesting was a possibility.  This 
study found that parents were not concerned about the consent process and felt screening is 
mandatory so consent is not necessary.  Parents desired information about newborn screening in 
the third trimester from their health care provider instead of after the delivery.  They requested a 
pamphlet of reading material to add to and reinforce the communication process.  For these 
parents, the essential information provided to parents should be brief and include the mandatory 
nature of screening, the benefits of screening, the potential for necessary retesting, and 
how/when parents would be contacted (Davis, 2006).  A 2006 qualitative study of the 
communication process between health care providers and parents on the topic of the newborn 
hearing screen supported these findings and identified a need to begin the communication 
process before birth and to provide supplemental reading material for parents to return to for 
more information (Arnold, 2006, “Infant hearing”).   
3.2.4 NEWBORN SCREENING FOR SICKLE CELL DISEASE 
The first statewide newborn screening program for sickle cell disease was initiated in New York 
in 1975.  In subsequent years, other states followed due to the availability of government funding 
through the Congressional National Sickle Cell Anemia Control Act.  This legislation provided 
funding for sickle cell screening of all children under the age of 7 and those individuals in their 
reproductive years.  However, it was not until 1986 that studies were able to show the benefit of 
taking prophylactic penicillin to prevent infection and early death in children with sickle cell 
disease.  This direct evidence of how early identification of affected children could allow for 
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beneficial treatment and decreased morbidity and mortality caused greater acceptance of 
hemoglobinopathy screening in other states.  Pennsylvania adopted newborn screening for sickle 
cell in 1990.  By 1996, the American Academy of Pediatrics recommended that every state 
implement targeted newborn screening for hemoglobinopathies for at-risk newborns (Olney, 
2000).  Currently, all states screen for hemoglobinopathies. 
Newborn screening for hemoglobinopathies including sickle cell disease is performed by 
isoelectric focusing in the majority of screening programs.  There are some programs that use 
high performance liquid chromatography as well.  If a result is not in the normal range, testing of 
that sample is repeated using the blood specimen from the original Guthrie card.  Confirmatory 
diagnostic testing must follow an abnormal screening result and should be completed before the 
infant is six weeks of age.  The diagnostic testing procedure is described in Table 1.  In those 
with sickle cell disease, prophylactic penicillin must be administered by two to three months of 
age (Pass, 2000).   
Table 1. Diagnostic Testing for Sickle Cell Disease (Pass, 2000) 
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3.2.5 KNOWLEDGE AND PERCEPTION OF SICKLE CELL AMONG AFRICAN-
AMERICANS 
A limited number of studies have been conducted to examine African-Americans’ knowledge 
and perception of sickle cell disease, sickle cell trait, carrier detection, and newborn screening.  
Past research has demonstrated a significant lack of awareness regarding the difference between 
disease and trait status and how trait status increases the chance to have a child with disease 
(Midence, 1994; Treadwell, 2006; Wright, 1994).  Specifically, one study of 147 African-
Americans between 18-50 years of age found that 31% knew if they were carriers for sickle cell 
trait (Wright, 1994).  A majority (73%) did identify that sickle cell is a genetic disease (Wright, 
1994).  Misconceptions of how one inherits sickle cell disease have also been documented 
among the African-American community.  Interestingly, a study of individuals with sickle cell 
disease found that 23% believed sickle cell trait could turn into sickle cell disease (Midence, 
1994).   
A 2006 study was undertaken to look more closely at African-American community 
members’ knowledge and misconceptions of sickle cell (Treadwell, 2006).  Three focus groups 
and 282 surveys were conducted in a metropolitan area of California (Treadwell, 2006).  Focus 
group participants were asked to identify barriers to follow-up counseling for sickle cell trait 
detected by newborn screening, to describe their understanding of sickle cell disease, and to 
suggest possible solutions for poor follow-up rates for sickle cell trait counseling (Treadwell, 
2006).  Common themes among community members who participated in these focus groups 
included limited visibility of sickle cell disease and trait and the need to use media to promote 
awareness (Treadwell, 2006).  Participants discussed the stigma associated with any type of 
 24 
disease in the African-American community and the need for health care professionals to have 
compassion and cultural sensitivity when discussing sickle cell (Treadwell, 2006).    
Surveys were designed to determine where individuals receive their information about 
sickle cell, what individuals currently know about sickle cell disease and trait, if individuals 
know their trait status, and the effectiveness of different sources of information in improving 
knowledge about sickle cell (Treadwell, 2006).  Among respondents, 86% could identify that 
sickle cell causes serious health problems, and 91% stated that sickle cell disease is most 
prevalent among African-Americans (Treadwell, 2006).  Approximately 86% of respondents 
knew that sickle cell disease is inherited from both parents, and slightly fewer respondents were 
able to correctly identify the reproductive risks of a sickle cell trait carrier (Treadwell, 2006).  
Eighty-one percent of individuals believed if you have sickle cell trait you have a chance to have 
a child with disease, and 78% of individuals believed a child with sickle cell trait would be at 
risk to have a child with disease in the future (Treadwell, 2006).  Of survey participants, only 
15.9% knew their trait status and of those individuals, 53% learned their trait status through 
discussion with family members (Treadwell, 2006).  The greatest majority of individuals receive 
their information about sickle cell disease and trait from friends and acquaintances (Treadwell, 
2006).  Respondents who received information from friends and family were three times more 
likely to know their trait status (Treadwell, 2006).  These findings emphasize the benefit of 
family discussion about sickle cell and the risk within a family.   
3.2.6 IMPACT OF GENETIC COUNSELING FOR SICKLE CELL DISEASE 
Genetic counseling for sickle cell disease and trait can occur in a variety of situations.  Couples 
or individuals may be referred to a genetic counselor to discuss carrier screening to learn of their 
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trait status before pregnancy occurs.  Others may be referred for prenatal genetic counseling after 
a pregnancy has occurred to perform parental carrier screening and/or prenatal diagnosis through 
chorionic villus sampling or amniocentesis.  For many individuals or families, the first encounter 
with genetic counseling for sickle cell comes after an abnormal newborn screen result.  This 
result often requires follow-up testing to determine whether a child has sickle cell disease or trait.  
Genetic counseling can provide families with information about genetic testing for parents and 
additional family members, the risk of recurrence for sickle cell disease and/or trait, the clinical 
picture of sickle cell disease, and information about resources and support organizations for the 
family.   
Research examining the impact of genetic counseling for sickle cell on the reproductive 
decisions of couples found that risk information did not have a significant impact on the number 
of affected children born to these couples.  This study followed 35 couples at risk to have a child 
with sickle cell disease.  The couples received genetic counseling after each member of the 
couple was found to be a carrier of sickle cell trait.  Of these couples, 40% did not believe the 
information would have an impact on their childbearing plans while 37% believed the 
information would influence reproductive decisions.  Of these 35 couples, 25 couples were able 
to be followed for between 1 and 120 months.  The study found that these 25 couples had 13 
children with sickle cell disease prior to receiving counseling and 10 children with sickle cell 
disease after genetic counseling occurred.  The authors attribute this lack of significant decrease 
in the number of sickle cell disease births to the relative ineffectiveness of family planning 
intentions and the intense desire to have children despite knowing the risks for disease (Neal-
Cooper, 1988). 
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Studies have also been conducted to examine how to improve the uptake of genetic 
counseling following an abnormal newborn screen result for sickle cell trait and ultimately, 
increase parental knowledge about risk for sickle disease in the family.  Prenatal genetic 
counseling for sickle cell disease and trait has been shown to improve the uptake of genetic 
counseling following an abnormal newborn screen result for sickle cell trait.  Yang et al 
demonstrated that women who received a brief description of sickle cell disease in the prenatal 
period were more likely to attend follow-up genetic counseling for identification of sickle cell 
trait on newborn screening in comparison to women who did not receive prenatal education 
(2000).  However, prenatal education did not reduce anxiety levels significantly among women 
who received an abnormal newborn screen result (Yang, 2000).   
A study conducted at the University of Pittsburgh found that implementing an intensive 
follow-up protocol for infants with an abnormal hemoglobinopathy trait identified by newborn 
screening increased the acceptance rate of genetic counseling (Kladny, 2005).  Follow-up 
protocol included letters, telephone calls, educational videos, and the possibility of providing 
genetic counseling over the phone or in person (Kladny, 2005).  Of the 52% of families who 
were reached by telephone, 92% accepted genetic counseling over the phone and 12% scheduled 
an appointment for genetic counseling in person (Kladny, 2005).  Prior to the implementation of 
the follow-up program, only 5.3% of those families reached by telephone received genetic 
counseling at that time (Kladny, 2005).  These strategies improve the uptake of genetic 
counseling services for families who receive an abnormal newborn screening result for sickle 
cell trait.  However, there still remains a significant portion of families and parents who do not 
receive information about the inheritance of sickle cell disease. 
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3.3 AFRICAN-AMERICANS AND GENETIC TESTING 
3.3.1 AFRICAN-AMERICANS’ ATTITUDES TOWARD GENETIC TESTING 
African-Americans’ attitudes and perceptions of genetic testing for the purpose of clinical 
diagnosis and management has been examined among individuals in clinical, educational, and 
community settings.  Despite the location from which subjects are recruited, participants 
articulate both benefits and risks of genetic testing.  Participants frequently express concern for 
possible misuse of information gathered from genetic testing but also identified the benefit of 
using genetic test results for prevention (Catz, 2005; Kessler, 2005; Laskey, 2003).    
In a study of attitudes toward genetics among minority populations, eight focus groups 
were conducted with 55 individuals recruited from community health centers (Catz, 2005).  Of 
these participants, fifteen were African-American and composed two focus groups (Catz, 2005).  
The greatest percentage (35%) of minority participants could not provide any information when 
asked what they had heard about genetic testing (Catz, 2005).  When asked more specifically 
about newborn screening, 45% were not aware that it is routinely performed (Catz, 2005).  
Minority participants stated the main benefit of genetic testing is that it can lead to prevention or 
preparation for disease (Catz, 2005).  However, participants also mentioned concerns for the 
unethical use of testing, anxiety from test results, and false reassurance from negative results 
(Catz, 2005).  Newborn screening was viewed as a method to prepare for a child’s health 
problems (Catz, 2005).  However, African-Americans and other minority participants expressed 
practical concerns for the outcome of genetic testing through newborn screening including 
concerns about insurability, financial burdens, parenting responsibilities for a sick child, and the 
potential to test positive for a disease with no cure (Catz, 2005).   
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A study by Zimmerman et al also examined African-Americans’ attitudes toward 
genetics in comparison to those of Caucasians through surveys in the community setting (2006).  
Results demonstrated a majority of both African-Americans and Caucasians believe that sickle 
cell disease is a genetic condition (Zimmerman, 2006).  In comparison to Caucasians, African-
Americans were more likely to believe genetic testing will lead to racial discrimination 
(Zimmerman, 2006).  Additionally, African-Americans were more likely than Caucasians to 
believe that all pregnant women should have prenatal genetic tests (Zimmerman, 2006). 
In contrast to the Catz et al. study which examined attitudes toward genetics among 
minorities with a range of educational levels, a study by Laskey et al. pursued similar 
questioning among African-American college students in a premedical program.  These 
undergraduates also stated that genetic testing could benefit individuals/families by allowing for 
prevention or preparation (Laskey, 2003).  However, the group’s overall concerns about the risks 
of genetic testing were more theoretical in comparison to the responses in the Catz et al study.  
Concerns about genetic testing included genetic discrimination, increasing abortion rates, 
eugenics, and breach of confidentiality (Laskey, 2003).   
3.4 QUALITATIVE RESEARCH 
3.4.1 QUALITATIVE RESEARCH METHODS 
Some qualitative research methods attempt to provide a comprehensive description of an event in 
everyday terms of those events (Sandelowski, 2000).  In contrast to quantitative methods, 
qualitative research is often a more interpretive approach where knowledge is gained from 
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observation (Beeson, 1997; Sandelowski, 2000).  Quantitative analysis uses descriptive statistics 
to summarize a finding but this form of analysis is limited by the pre-selection of variables to be 
studied which are based on the assumptions of the researchers (Sandelowski, 2000).  Qualitative 
research opens the door for the unanticipated responses of participants by allowing for free 
description instead of confining individuals to items on a survey (Sandelowski, 2000).  Beeson 
describes the depth of qualitative research method when she states, “…Instead of attempting to 
prove or refute a hypothesis, or posing alternatives and offering to discover which one is most 
accurate, you formulate your research question in such a way that you can reveal whatever 
processes are actually occurring.  Your research question should reflect this goal by asking not 
simply what people do, but why they do it, or how they make sense of a particular situation- 
what it means to them” (1997).  This process allows researchers to find facts and the meanings 
participants attach to those facts (Sandelowski, 2000).   
Qualitative research methods are often divided into two frameworks: dependent on a 
theoretical position and independent of a theoretical position (Braun, 2006).  The types of 
analyses which are tied to a theoretical position may have limited variability in how they are 
performed (Braun, 2006).  These include interpretative phenomenological analysis, conversation 
analysis, grounded theory, discourse analysis, and narrative analysis (Braun, 2006).  Thematic 
analysis is a qualitative method independent of theory, and it is this flexibility which provides for 
the wide range of use for this research tool (Braun, 2006). 
3.4.2 THEMATIC ANALYSIS 
Thematic analysis is a qualitative research method for identifying, analyzing, and reporting the 
patterns or themes within the data collected (Braun, 2006).  This method is most often used when 
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the research project is attempting to examine a topic where little is known or where the views of 
participants on a topic have not been well documented (Braun, 2006).  Thematic analysis 
provides room for the unanticipated responses of participants.  The established themes of this 
analysis are crucial to obtaining a rich description of the data.  A theme is defined as capturing or 
representing a patterned response or meaning within the data (Braun, 2006).  However, it is 
important not to fall into the trap of believing repetition of a theme means it is more critical to 
understanding the topic than other themes.  There is no established rule stating that an idea has to 
be displayed in a certain percentage of the data for it to be considered a theme (Braun, 2006).  
However, it is essential for a theme to capture something important to answering the overall 
research question (Braun, 2006).  The researcher must take a very active role when analyzing the 
data according to thematic analysis so as to identify patterns or themes, select those of interest, 
and report them accurately (Braun, 2006).   
Before embarking on thematic analysis, researchers must decide their approach to coding 
and the level at which themes will be identified.  Thematic analysis is often conducted in either 
an inductive or deductive manner.  If an inductive approach is performed, then data is coded 
without trying to adhere to a pre-existing coding system (Braun, 2006).  The preconceptions of 
the researcher do not play a strong role in this form of analysis and themes are created based on 
what is found in the data (Braun, 2006).  In contrast, a deductive approach focuses on coding 
according to currently existing theories or previous analyses on the research question (Braun, 
2006).  In general, this type of analysis may not capture the overall picture or description 
provided by participants (Braun, 2006).  After an approach to coding has been determined, it is 
important to assess whether or not it will be appropriate to identify themes at an explicit or 
interpretative level (Braun, 2006).  Explicit themes capture the surface meaning of what a subject 
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or participant has written or said while interpretative themes attempt to examine the underlying 
ideas, assumptions, and conceptualizations shaping the surface theme (Braun, 2006).  When an 
approach and level to coding has been determined, the process of data analysis can begin.  This 
process often consists of phases including becoming familiar with the data, generating initial 
codes, searching for themes, reviewing themes, defining and naming themes, and producing the 
final report (Braun, 2006).  At the conclusion, the goal of this approach is to tell an overall story 
of the data (Braun, 2006). 
Table 2. Phases of Thematic Analysis (Braun, 2006) 
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4.0  MATERIALS AND METHODS 
The study design was approved by the University of Pittsburgh’s Institutional Review Board 
(IRB) on November 16, 2006 (Replications of IRB Approval letters for protocol # 0610018 can 
be found in Appendix A). 
4.1.1 PARTICIPANT RECRUITMENT 
This study was designed to recruit African-Americans from Pittsburgh, Pennsylvania who are 
members of the Healthy Black Family Project (HBFP), a community based health promotion and 
disease prevention program sponsored by the Center for Minority Health of the University of 
Pittsburgh.  Both males and females over the age of 18 years were recruited.  Individuals who are 
members of the HBFP typically reside in the predominately African-American communities of 
Pittsburgh.  These communities are defined as the Health Empowerment Zone (See Table 3 and 
Figure 3) by the Center for Minority Health.  The HBFP is strategically housed within this zone 
at the Kingsley Association.  The Kingsley Association is a community recreation and meeting 
center located in East Liberty, Pennsylvania which supports the efforts of the HBFP and permits 
use of its facilities for physical fitness classes, community discussions, and support group 
meetings.   
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 Table 3. Health Empowerment Zone 
Zip Code Neighborhood 
15147 Penn Hills 
15206 Lincoln, Lemington, Belmar, East 
Liberty, Larimer, Garfield 
15207 Glen Hills 
15208 Point Breeze North, Homewood South, 
Homewood North, Homewood West 
15213 Terrace Village, Upper Hill 
15219 Crawford Roberts, Terrace Village, 
Middle Hill, Bedford Dwellings, Upper 
Hill 
15221 Homewood North, East Hills, 
Wilkinsburg 
15224 Garfield 
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Figure 3. Health Empowerment Zone Map (1 dot = 100 African-Americans) 
 
Subjects recruited can be divided into two categories: individuals who are members of 
the Healthy Black Family Project but not the Minority Research Recruitment Database and 
individuals who are members of both the HBFP and the Minority Research Recruitment 
Database.  The Minority Research Recruitment Database is a feature of the HBFP which is 
offered to individuals who complete their family health history with a genetic counseling student.  
It was developed as an effort to increase African-American and minority participation in 
research.  The database is composed of names, addresses, telephone numbers, and personal and 
family health information of those individuals who would like to be contacted in the future for 
research studies.  Participants provide written informed consent to be included in the database.  
For those individuals who are members of the HBFP but not the Minority Research Recruitment 
Database, contact was made for this study through flyers posted at the Kingsley Association and 
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advertisements in the HBFP monthly mailings (See Appendix B).  The flyer stated the topic of 
genetics but did not specifically mention sickle cell or newborn screening.  Individuals who saw 
a flyer then contacted the researchers to sign up for a focus group.  For those individuals who are 
members of both the HBFP and the Minority Research Recruitment Database, contact was made 
by telephone and the study was presented according to a telephone script (See Appendix B).  
Telephone calls were made at several times of day on both weekends and weekdays to be as 
inclusive as possible.  At the time of recruitment, participants were also notified that focus 
groups would require 2 hours of time, and they would receive refreshments and a $25 gift card to 
Giant Eagle, a grocery store located in Pittsburgh, for their commitment.  After signing-up for a 
focus group, each participant received a reminder letter in the mail (See Appendix B) and a 
follow-up phone call the day before his/her scheduled focus group.   
4.1.2 FOCUS GROUPS 
Four focus groups were conducted over a period of two months in December and January of 
2006-2007 at the Kingsley Association.  The Kingsley Association was selected as the location 
for the focus groups because it is a familiar building for HBFP participants and is closely located 
to where a majority of HBFP participants reside.  For each focus group between 10 and 15 
individuals were recruited with an expectation that due to cancellation or no show approximately 
10 individuals would attend the group.  The four focus groups were conducted at a variety of 
times and days of the week in order to gather as many participants as possible.  The groups were 
held on two Saturdays at 2 PM, Wednesday at 6 PM, and Thursday at 6 PM.  The groups 
consisted of 11, 6, 10 and 8 participants for a total of 35.  Each group was held in a community 
room of the Kingsley Association, and participants sat together at a common table for discussion.  
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Audio recordings of the focus groups were collected for later transcription and notes of the 
discussion were taken by an assistant to the moderator.  Each focus group began with 
participants choosing an alias to use during discussion and then completing a pre-discussion 
survey.  Focus groups were conducted according to a moderator’s guide found in Appendix C.   
4.1.3 SURVEY 
Each participant was asked to complete a survey designed to characterize demographics and 
experience with sickle cell trait and disease (See Appendix D).  The survey was designed to take 
approximately 10 minutes to complete and consisted of 19 questions.  The survey is separated 
into two sections.  The first section focuses on demographic questions and information about 
genetics knowledge, personal health, and health insurance status.  The second section is directed 
at the participant’s familiarity with sickle cell disease and trait and knowledge of personal trait 
status and trait status within his/her own family.  Information gathered from the administration of 
this survey was analyzed using Microsoft Excel.   
4.1.4 TRANSCRIPTION 
The audio tapes for each focus group were transcribed word-for-word by a transcriptionist 
employed by the Center for Minority Health.  Microsoft Word was used to manage the four 
transcripts.  Transcripts adhered to participants’ grammar, pauses, place holders, and unfinished 
sentences but have been edited in some cases to be more understandable by the reader.   
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4.1.5 QSR NUDIST VIVO® AND CODING 
The QSR NUDIST VIVO® software is a program designed to manage and facilitate analysis of 
qualitative data.  NUDIST is an acronym for Non-numerical Unstructured Data Indexing, 
Searching, and Theorizing.  The NVIVO program allows transcripts or other qualitative data to 
be uploaded into the software where the researcher can then store and analyze the data.  The 
program is designed to permit the researcher to develop his/her own codes and apply those 
throughout multiple transcripts in one project. These codes or nodes can be further broken down 
and linked by node trees in order to generate a thematic map of the data.  The software allows the 
researcher to capture all direct quotations labeled by a particular node from across all transcripts.  
This feature is helpful for comparison of themes during analysis. 
Before applying the NVIVO program to the transcripts of this study, each transcript was 
read twice by the researcher to gain familiarity with the data and the audio tapes were listened to 
once while reading each transcript to ensure reliability.  As the transcripts were read, the 
researcher wrote down notes of potential themes and other features of the data.  After performing 
the background research of this study and reading the transcripts, it was determined that the 
inductive approach to thematic analysis would best capture the responses of this population and 
allow for the unanticipated.  The use of interpretative themes is most fitting for the research 
questions of this project in the attempt to understand the underlying ideas, attitudes, and 
assumptions which shape African-Americans’ views of sickle cell.  However, explicit themes are 
necessary for some topics.   
The transcripts were uploaded to NVIVO and codes were generated to reflect the 
participants’ views and opinions according to thematic analysis.  Codes were revised throughout 
the process in order to better refine and capture the beliefs of participants.  Some passages of the 
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transcript required only a single code while other passages required multiple codes due to the 
richness of the information.  The NVIVO software then allowed comparison of codes across 
transcripts to create a theme which summarizes the views of multiple individuals. 
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5.0  RESULTS 
5.1 SURVEY RESULTS 
5.1.1 DEMOGRAPHICS  
A total of 35 individuals participated in the focus groups and completed the pre-discussion 
surveys.  The average age of participants was 53 years with a median age of 57 years and range 
of 26-77 years.  Of these individuals, 91% are female and 91% are African-American.  The 
remaining 9% of individuals categorize their race as “Other”.  Approximately 82% of 
participants have children.  The majority of participants has an income between $20-35,000 
(32%) and has an educational background of 1-3 years of college or technical school (40%).  
When asked about personal health, 57% indicated they are in good health, 54% believe they are 
overweight, and 17% are smokers.  Approximately 97% have a form of health insurance, 57% 
have one personal physician, and 17% could not go to the doctor within the last year because of 
cost.  (See Figures 4-13). 
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Figure 4. Racial Demographics of Focus Group Participants (N=35) 
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Figure 5. Percentage of Focus Group Participants with Children (N=34) 
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Figure 6. Income Levels of Focus Group Participants (N=34) 
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Figure 7. Education Level of Focus Group Participants (N=35) 
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Figure 8. Rating of Personal Health among Focus Group Participants (N=35) 
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Figure 9. Description of Personal Weight among Focus Group Participants (N=35) 
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Are you a smoker?
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Figure 10. Smoking Status among Focus Group Participants (N=35) 
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Figure 11. Health Insurance Status among Focus Group Participants (N=35) 
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Do you have one personal doctor?
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Figure 12. Number of Personal Physicians among Focus Group Participants (N=35) 
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Figure 13. Ability to Attend Physician Appointment Based on Cost among Focus Group Participants (N=35) 
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5.1.2 FAMILIARITY WITH GENETICS AND SICKLE CELL 
A pre-discussion survey assessing personal rating of genetics knowledge and familiarity with 
sickle cell trait and sickle cell disease found that a majority of individuals believe they have a 
fair knowledge of genetics (47%) and a majority knows someone with sickle cell trait (64%) and 
someone with sickle cell disease (64%).  Of those individuals who know someone with sickle 
cell trait or disease, 20% know an individual who was found to have trait or disease by newborn 
screening.  (See Figures 14-17). 
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Figure 14. Rating of Personal Knowledge of Genetics among Focus Group Participants (N=34) 
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Figure 15. Knowledge of Someone with Sickle Cell Trait among Focus Group Participants (N=34) 
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Figure 16. Knowledge of Someone with Sickle Cell Disease among Focus Group Participants (N=34) 
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Do you know someone found to have SC disease or trait by 
newborn screening?
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Figure 17. Knowledge of Someone with Sickle Cell Disease/Trait Detected by Newborn Screening (N=34) 
 
5.1.3 KNOWLEDGE OF PERSONAL AND FAMILIAL SICKLE CELL TRAIT 
STATUS 
The majority of participants do not know their own sickle cell trait status (51%).  For those 
individuals with a spouse or partner, only 26% know that individual’s sickle cell trait status.  
Among participants with children, only 40% know their child or children’s sickle cell trait status. 
(See Figures 18-20).  
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Do you know your SC trait status?
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Figure 18. Knowledge of Personal Sickle Cell Trait Status among Focus Group Participants (N=33) 
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Figure 19. Knowledge of Spouse/Partner’s Sickle Cell Trait Status (N=34) 
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If you have children, do you know your child's SC trait status?
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Figure 20. Knowledge of Child/Children’s Sickle Cell Trait Status (N=27) 
5.2 THEMATIC ANALYSIS 
5.2.1 ASSESSING AFRICAN-AMERICANS’ ATTITUDES AND BELIEFS ON 
GENETICS 
Initial focus group discussion began with conversation about participants’ impressions of 
genetics and what the word means to them.  Through this conversation, participants identified 
their primary resources for genetics information as high school and college coursework, 
experiences on the job or as a participant in research studies, physicians, the media, and family 
and friends (Table 4).  The educational background of focus group participants ranged from 
completion of high school to graduate school, and therefore, the exposure to biology and genetics 
course work varied for each individual.  The majority of individuals who stated their educational 
background is a primary resource for genetics education also explained that they had advanced 
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degrees or multiple courses in biology.  One woman stated, “I have a degree in biology so I had a 
lot of courses in different areas.”  Other individuals discussed on the job experience with 
genetics such as “I worked in a research lab…and we get lots of medical information.”  Two 
individuals mentioned their participation in genetics research which provided them with first-
hand experience and knowledge of genetics.  For many individuals, the primary care physician 
provides genetics information and often the first conversation about the importance of family 
history.  As a participant describes here, “A lot of times you go see doctors, and if you are a first 
time patient, they ask a lot of questions about the medical family history.”  Another individual 
stated, “Especially when something goes wrong with you and they’ll come in and introduce 
themselves and bring up your background and it will come up that way.”  The greatest number of 
participants discussed relying on information gathered from the media to understand genetics.  
Media influences included the internet, newspaper, magazines, and television programs 
including those for entertainment, health and science information, and news. 
 The theme of using family and friends as a primary resource for health/genetics 
information was highlighted over the course of focus group conversations.  In general, 
participants valued a particular individual as a resource because of his/her association with the 
medical profession and a feeling of familiarity and trust.  One woman describes her relationships 
with friends and family: 
I think that is true that the black community will have someone that works at a hospital or 
has been at a hospital for a long period of time and by that I mean my sister she’s 72 and 
we consider her the physician of the family.  She has the PDR’s.  She’s had a long time 
experience with different illnesses and various things.  My girlfriend she’s worked at 
Allegheny General for 25 years when I want a specialist but that is the way I think it 
happens.  I think in the black community too is that word of mouth. 
 
Another participant describes how she relies on friendship to help understand health information: 
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I have a friend who is a physician’s assistant so every now and then we’ll have like a 
woman session.  If she’s there but if that’s not what we’re talking about we just get 
together every now and then for fun but if there is anything we need to discuss we ask 
her. 
 
The theme of the importance of familiarity with the health professional as a component of the 
information sharing process appears again during discussion of the dissemination of newborn 
screening information. 
Throughout each focus group discussion, individuals were able to characterize what 
genetics means to them.  During these moments of conversation, distinct themes emerged 
including genetics is inheritance, genetics is defined by technical terms, genetics is defined by 
the media, and genetics is influenced by the environment (Table 4).  The majority of individuals 
situated their understanding of genetics within the context of inheritance or “traveling down the 
line from generation to generation.”  There were some individuals who expressed a feeling that 
genetics is inescapable and that the health of past relatives has an effect on the current individual.  
Participants stated that “Inheritance is something that you are born with.” and “Your 
chromosomes, the X and Ys and then that determines certain elements (pause) if you have pre 
diagnosis history.”  In contrast, there were participants who discussed how genetics can be 
shaped by environmental influences such as nutrition or how a mother’s health can impact the 
outcome of a pregnancy.  For example, a woman described the connection between mother and 
baby, “Sometimes if the blood pressure is up they will put you on bed rest because it definitely 
will have an affect on you as well as the child.”  Many individuals used technical language such 
as “genes” and “DNA” to describe what genetics meant to them and made statements such as 
“When a child is born you get DNA from your parents, mother and father, and of course, your 
DNA is made up of all the past DNA and so you get half and half and you are who you are.”  
Other individuals described genetics by using popular media stories such as actor Michael J. Fox 
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and stem cell research or media icon Oprah Winfrey and tracing African heritage.  A participant 
discussed how media shapes her view of genetics in the following passage: 
I’ve heard the word genetics used in trying to trace back our ancestors.  Oprah was 
talking about it where she was trying to find as far back as she could reach with the 
testing of genetics seeing where her racial boundaries were and I found that to be quite 
fascinating. 
 
The news and entertainment stories which participants chose to describe genetics had a great deal 
of attention in the media during the time period these focus groups were conducted.   
Table 4. Attitudes and Beliefs about Genetics 
Primary Sources of Genetics Information Definition of Genetics 
• Education 
• Employment 
• Research participation 
• Physician 
• Media 
• Family/Friends 
• Inheritance 
• Defined by technical terms 
• Defined by the media 
• Influenced by the environment 
5.2.2 ASSESSING AFRICAN-AMERICANS’ ATTITUDES AND BELIEFS ON 
PRENATAL TESTING 
Over the course of focus group discussions, participants were able to correctly identify methods 
of and indications for prenatal testing and converse as a group about the benefits and 
risks/limitations of prenatal testing.  Within each focus group, there were several individuals who 
had recently undergone prenatal testing or knew a friend or family member who had experienced 
prenatal testing.  Participants identified ultrasound, amniocentesis, and viral studies as prenatal 
tests but did not use these words explicitly (Table 5).  A young woman referred to amniocentesis 
as “Being tested while you are pregnant with the long needle thing in your stomach.”  When 
identifying the types of prenatal tests available focus group participants fell into either one of 
two categories: chromosome testing and DNA testing (Table 5).  Most frequently individuals 
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mentioned chromosome testing for Down syndrome.  “I always think of chromosomal problems 
like Down syndrome and different problems that happen when you are pregnant and they can tell 
through prenatal testing.”  Sickle cell testing was the only DNA test mentioned during 
discussion.  “A lot of black kids have sickle cell they might be able to detect that.”   
Table 5. Attitudes and Beliefs about Prenatal Testing 
Prenatal Testing Methods Prenatal Testing Indications 
• Ultrasound 
• Amniocentesis 
• Viral studies 
• Chromosome testing: Down syndrome 
• DNA testing: Sickle Cell 
 
 Overwhelmingly, participants voiced the opinion that prenatal testing has multiple 
benefits.  Themes which emerged during conversation about the benefits of prenatal testing 
included the value of awareness and the value of choice (Table 6).  Participants within each 
focus group were able to identify the benefit of having information about the pregnancy.  
However, some believed this awareness would ultimately benefit the pregnancy and the baby 
while others discussed how this awareness would benefit the mother or the family.  Several 
participants brought up the potential to correct a health problem that is identified prenatally: 
“Can’t they do surgery while the baby is inside if they find something in order to help the baby 
before they come out.”  Another participant stated prenatal testing was performed “to see what 
they can try and fix.”  Some individuals felt a health problem identified prenatally would allow 
the child to receive the appropriate care in the newborn period:  
When a child through prenatal you find out something is wrong with that child and that 
child is born, if you know before you leave the hospital you can treat things so much 
differently-even different formulas and stuff.  If you have a child with different types of 
diseases or something, you have to be very careful with.  So if you know before hand, 
then you don’t make the mistake of hurting your own child from not knowing. 
 
Awareness of a genetic condition during the prenatal period also benefits the mother and the 
family.  For some participants, awareness of a genetic condition allows the mother to be 
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knowledgeable about possible recurrence and in select cases, make changes to lower the chance 
of recurrence.  One woman described how parental awareness could help prevent spina bifida:   
You could probably take that information to your next pregnancy.  When you get 
pregnant again, if your body was too low with a certain vitamin or some type of nutrition 
you didn’t have while you were pregnant, you could try to boost up on that before you get 
pregnant the next time so you won’t have to face any difficulties or anything like that. 
 
Additional focus group discussion of the value of parental awareness highlighted the importance 
of how awareness leads to personal choice. 
 The choice described by participants was often between termination or continuation of a 
pregnancy in light of prenatal test results indicating the child would have a genetic or other 
health condition.  However, there was another faction of focus group participants who described 
the choice as whether or not to undergo prenatal testing.  The importance of choice in situations 
which affect the family is described by a participant who stated: 
People have a right to make individual choices.  They have a right to make family 
choices.  You can look into things and you can take part in genetic testing or the 
procedure you were talking about as far as amniotic fluid, but I don’t know it still has a 
lot to do with human choice. 
 
Several individuals stressed the value of choice when deciding whether or not to continue a 
pregnancy if a genetic condition has been detected by prenatal testing.  One woman felt that 
prenatal testing is performed “to see if there is any deformity in the child and then it gives the 
mother the right to say whether or not she wants to go full term.”  Another participant pointed 
out that the choice to continue a pregnancy is often presented by the physician: 
There also are certain diseases that run in certain races and so this kind of testing while 
baby is still in utero can help identify them.  For instance, Tay-Sachs is a disease that 
runs in certain groups of people and retardation and certain things like that.  So if you 
know in the first term, then the doctor will say to you, you can make a decision at this 
time to go forth to go full term or you can terminate therapeutically at this point in time 
and so that’s one very good reason why genetic testing in terms of prenatal is so 
important. 
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The value of choice becomes important for each woman or couple when assessing whether or not 
he/she will be able to care for a child with a genetic health condition.  During conversation a 
participant brought up this point when she said “…Sometimes too they can detect different birth 
defects before the person is full term to see if that person is able to take that child because the 
child is going to come deformed or something or maybe its better medically to abort that child.”  
However, no participant mentioned specific social situations or financial situations which would 
cause a person to choose to terminate a pregnancy.   
 Community members also valued the opportunity to choose whether or not to have 
prenatal testing.  For some individuals, the detection of a health problem in a pregnancy would 
cause overwhelming stress and he/she would prefer to be ignorant of a problem throughout the 
course of the pregnancy.  These individuals demonstrated that they are aware of their personal 
limitations in the ability to handle stress.  This feeling is captured by the sentiments of a female 
participant: 
I think if you know that you are not going to terminate the child and then you know there 
is something wrong with it, it could be real stressful for you which would also be a 
problem for the baby.  So if you are going to do it, I think you should decide before that if 
you do want to terminate it, but if you don’t, I don’t think you really should know ahead 
of time.   
 
Another participant discussed her personal experience deciding whether or not to undergo 
prenatal testing: 
When I was trying to get pregnant, my husband and I, we had a very difficult time getting 
pregnant so then they say once over 40 if you get pregnant you may be more at risk.  So 
then they were going to test and I said if I am not going to terminate why would I want to 
test because it will just make me more anxious to have another miscarriage. 
 
For these and other individuals, it is important to think through the decision to have prenatal 
testing and to choose what will be of benefit to their life and situation. 
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Focus group participants identified fewer risks than benefits of prenatal testing, but 
participants placed significant emphasis on the risk to lose the pregnancy, the possibility test 
results may cause stress on the marriage or family relationship, and chance that prenatal test 
results are inaccurate (Table 6).  When asked to identify potential risks of prenatal testing, many 
made statements such as “You could have a miscarriage.”  There was also a subset of individuals 
who believed the real risk came not from the prenatal test but from the treatment for the 
condition identified by the prenatal test.  One woman described her fear of electronic monitors 
used during labor and delivery: 
A lot of these doctors want to go up and they are fooling around and do damage to these 
unborn.  You know just like they want to stick these monitors on these kids.  I didn’t 
want it.  They did it, and I told them if anything happens I’m suing you because I don’t 
think you should be putting things on babies’ heads. 
 
Another woman feared the medication which may need to be administered to the mother to treat 
the baby and stated, “I think a disadvantage comes when you have to give medication or 
whatever and that medication has an adverse reaction.”  Not only did participants fear prenatal 
testing could harm the fetus but they also expressed concern about the impact of prenatal test 
results on family relationships.  One participant characterized a possible interaction between a 
couple experiencing the process of prenatal testing: 
(Prenatal testing is performed)…To see if there is any deformity in the child and then it 
gives the mother the right to say whether or not she wants to go full term because it may 
be traumatic to raise a child with special needs.  So they give the parents cause they tell 
them to have a conference to decide what they want to do and sometimes doing that it 
will split up a family because mom says ‘I’m having my child I don’t care what is 
wrong.’ and dad is like ‘I’m not putting up with a child that has some special needs.’ and 
so now you don’t have a dad in the picture because he just felt he can’t handle that kind 
of situation and so a lot of women won’t take it.  They’ll just say we’ll find out what 
happens when the child gets here. 
 
Stress on a relationship is an important consideration in the decision whether or not to pursue 
prenatal testing despite the benefits named by participants.  Participants also voiced concern 
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about the possibility of inaccurate test results and the stress which may emerge when considering 
this possibility.  This theme of distrust of prenatal test results is captured in the following 
passage: 
I had prenatal testing and the whole time we waited for the test results I think I stressed 
myself.  Like I worried about it so much it was like I don’t know just cause more 
aggravation.  That is the only thing I didn’t like about the prenatal testing was like you 
had to wait and after the baby came out more testing and none of the results were true 
cause like the sonograms weren’t really efficient.  They could see some degree of the 
child, but they are not really that great so it was like I am more worrying. 
 
In some cases, the perception of the inaccuracy of prenatal testing is shaped by frustration with 
the test’s limitations.  In the previous statement, the participant understood that ultrasound 
cannot detect or characterize all health conditions but still expressed anxiety that further testing 
would be required for her child.   
Table 6. Risks and Benefits of Prenatal Testing 
Benefits Risks/Limitations 
• Value of awareness 
• Value of choice 
• Risk of miscarriage 
• Relationship stress 
• Possible inaccurate results 
5.2.3 ASSESSING AFRICAN-AMERICANS’ ATTITUDES AND BELIEFS ON 
NEWBORN SCREENING 
Focus group discussion revealed three distinct themes characterizing participants’ knowledge of 
newborn screening: those who are unaware, those with accurate but incomplete knowledge, and 
those with misinformation (Table 7).  The greatest majority of focus group participants did not 
respond or made movements such as shoulder shrugging to indicate uncertainty when asked to 
describe newborn screening.  Common responses indicated a lack of awareness such as “Never 
heard the phrase (newborn screening)” and “So is this (newborn screening) something new?  I 
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mean, how recent?”  Each group contained at least one individual who was able to identify a 
genetic condition which can be detected by newborn screening.  Specifically, individuals 
correctly believed sickle cell, cystic fibrosis, and phenylketonuria are screened for in the 
newborn period.  However, none of these individuals identified that newborn screening is a heel-
stick blood test performed in the first days of life.  Interestingly, one participant accurately 
identified that the number and type of condition tested for by newborn screening varies from 
state to state.  “There is a lot (of tests) out there and Pennsylvania probably only does 9 or so, but 
there are other states who do.  So I don’t know if our state should do more or if that is a 
requirement of the parent.”  This participant is accurate in her understanding of the differences 
between state programs but indicates that she still has incomplete information as to who decides 
what is included on a screening panel.  In contrast to participants with accurate but incomplete 
information, there were a number of individuals who are misinformed about the use of newborn 
screening and who were unable to provide an accurate description.  These participants cited 
blood type, heart murmur, diabetes, prenatal drug exposure, jaundice, and asthma as conditions 
tested for by newborn screening.   
Table 7. Knowledge of Newborn Screening 
Knowledge of Newborn Screening 
• Unaware 
• Accurate but incomplete knowledge 
• Misinformation 
 
Participants only identified benefits of newborn screening after a common definition of 
the process was shared by the focus group moderator.  The benefits of screening included themes 
of preparation and treatment (Table 8).  With each of theses themes, the benefit indicated by the 
participant was for the child and not for the parent or family.  Individuals expressed a desire to 
have the information gathered from newborn screening to prepare to care for that child in the 
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appropriate way.  One mother discussed the importance of knowing her child had a genetic 
condition called glucose-6-phosphate deficiency or G6PD in order to protect him from 
substances which could aggravate his condition. 
My son, I adopted him, he was an infant and he had G6PD - something I knew nothing 
about.  So it was good to know that - to have that information from the hospital. I know 
what not to have around him, what not to give him especially like aspirin, no mothballs 
around him.  Cause my mom is from the old school.  She used to have mothballs so I was 
real glad that I knew. 
 
Another participant focused on the value of knowledge and the sense of security from being 
aware of a child’s genetic condition.  “You need to know what to look for.  If it’s there, if 
something happens, you need to know what you’re dealing with.”  There were also participants 
who valued advance knowledge to prepare the appropriate services for a child in order to 
maximize his/her potential.  For example, “I think of to get as much early intervention as 
possible to help the child in ways that the child could be stimulated.”  The possibility for early 
treatment when a condition is identified by newborn screening was also explored by participant 
discussion.  “I know you can test for a lot of conditions that can be treated within the first 3 
months you can give medication to the baby to be okay.”  This participant recognized the 
potential to provide treatment to prevent the effects of an untreated genetic condition.  The 
concept of using awareness and treatment to improve the outcome for a child with a serious 
condition is also elucidated in these comments: 
…And with cystic fibrosis at least they can start a plan of treatment so the child can have 
a productive or as much of a productive life as possible as opposed to finding out when 
they’re older and now, you’re starting from scratch when you could have prevented 
something.  It’s the same thing like a child that is diagnosed with autism.  If it’s further 
down the road, then you’re behind the eight ball.  Where as if you find out early enough, 
you can start doing things to help get the child in the right direction and get them in 
mainstream. 
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This participant and others articulated the benefit of knowing a genetic condition is present in 
order to provide a child the best care and opportunities for a healthy life.  Conversation 
demonstrated that when individuals are provided with accurate information about newborn 
screening they find it to be a valuable service which improves the ability to care for their 
child/children.   
Table 8. Benefits of Newborn Screening 
Benefits of Newborn Screening 
• Preparation 
• Treatment 
 
5.2.4 KNOWLEDGE OF SICKLE CELL DISEASE AND TRAIT 
Analysis of participants’ conversation about sickle cell disease and trait identified the primary 
theme of reliance on experience (Table 9).  Each participant referred to witnessing an 
acquaintance, family member, or friend living with sickle cell disease or sickle cell trait when 
describing a feature of the condition or its inheritance.  These experiences allowed participants to 
speak confidently as they described the symptoms of the disease such as pain, weakness, and 
shortened lifespan.  One woman describes what she has learned about pain crises from talking 
with a co-worker: 
I have a friend she is a co-worker and she has a daughter that has it.  She has a son he 
doesn’t but her daughter has had it since birth and what I’ve noticed is it seems like the 
older she is getting, because she just turned 13, the older she is getting the more episodes 
or crisis.  It’s painful.  Her mother tells me she can’t even get out to walk and she’s 13 
and she only stand this tall.  She has had bouts in the hospital.  They have to put her on 
morphine so you can imagine a little body like this it affects her psychologically.   
 
Another speaks about the pain he witnessed when a family member went into a crisis stating, “I 
do know it’s very painful very, very painful because he used to ball up just fall on the floor and 
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he’d be in a ball crying.”  One participant who was a junior high school teacher articulated her 
interaction with a student diagnosed with sickle cell disease.   
If you’ve ever watched a child suffer from sickle cell- I had students that had sickle 
cell…I was her teacher.  She broke my heart to watch her sit in my classroom and the 
pain that she suffered with and to know she suffered all her life and even sadder, was she 
knew she was never going to see 50 the way her health was.   
 
This quotation also highlights the belief that sickle cell disease shortens the lifespan.  When 
describing the symptoms of sickle cell disease, participants referred to individuals they had seen 
pass away at young ages and made statements such as “When I was younger, there was a girl she 
lived to the age of 12, and she had sickle cell” and “I had a friend who had sickle cell and she 
would go into a crisis quite a bit.  She didn’t survive.  She passed away in her early 30s.”  When 
discussing additional symptoms like weakness/tiredness, individuals continued to voice personal 
experience observing sickle cell disease in the family or community.  “My husband’s niece has it 
and the only thing I know she gets very weak and has to have a lot of bed rest.”  Another 
participant based her knowledge of sickle cell disease symptoms on children she has observed in 
her church. 
…If they get over exerted like there are some young girls at church that are involved in 
everything and they are involved in their school activities so what happens with them is 
when they are just over extended for some reason that brings about an episode. 
 
 In addition to articulating an understanding of sickle cell disease symptoms, several focus 
group participants were able to identify the cause of symptoms and the differences between 
disease and trait.  Some were able to connect the name of the condition to the abnormal shape of 
the cell.  Statements included “…From what I understand it’s like your cells are an abnormal 
shape” and “The shape of the cell is like a moon or crescent or something and it stops the flow of 
the blood.”  Participants distinguished sickle cell disease from sickle cell trait by the presence or 
absence of symptoms and again relied on personal experience to make this distinction.   
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I had a friend who had sickle cell and she would go into a crisis quite a bit.  She didn’t 
survive.  She passed away in her early 30s and in her family there were a number of 
people who had the trait and when you asked the question, the main thing I thought of 
was the trait don’t go into crisis situation. 
 
 Participants’ reliance on personal observation of individuals with sickle cell disease and 
trait in order to understand the condition also led to significant misconceptions about the 
inheritance pattern.   Individuals understood that sickle cell disease and trait runs in families.  
“Right so it has to be genetically in that family - older sister had it (sickle cell disease) and one of 
her brothers had it and one died from it.”  However, there was significant uncertainty and 
misconceptions that emerged as participants attempted to make sense of the pattern of disease 
and trait seen within a family.  Some individuals questioned why only some children have 
disease when each parent has trait.   
You would think, at least I do, if the mother or the father or both that all the siblings 
would have it.  Why is it maybe just one out of three or four may have it and the other 
ones no? 
 
Other participants were uncertain as to why sickle cell disease would appear for the first time in 
a family. 
My grandson’s cousin he was the first in our family or someone that I knew that had 
sickle cell.  I mean it was a surprise to me that his first cousin was born with sickle cell 
and then later on, my grandson, my daughter’s son, has a trace of sickle cell.  So I don’t 
know where that came from.  It was surprising to me that he has the trait.  I am clueless 
as to whether he received that from his father because I know of no one on my side of the 
family that ever had that that I am aware of. 
 
One woman observed a pattern where only females were carriers of sickle cell trait in her family.   
“I have the sickle cell trait and when you were talking about different family members that have 
it, it seems like the females in my family have it.  I had the trait, my daughter, my sister.”  
Participants did not articulate what they believe the chances are to have a child with sickle cell 
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disease when each parent has trait nor did they discuss the chance for a child to inherit sickle cell 
trait when one or both parents have trait.   
 Apart from discussion about the inheritance and clinical features of sickle cell disease, 
participants were keenly aware of the social issues that emerge from a sickle cell disease 
diagnosis.  Again participants focused on their observations of family dynamics when a child has 
sickle cell disease.  This participant described the stress in a family as they try to manage caring 
for a sick child.   
I watch my friend.  I ache for her because unfortunately we both work for a major 
corporation - I won’t mention - but the area she works in they don’t show sympathy for 
the time she needs to be off when her daughter is in the hospital and she’ll spend the 
night at the hospital and she’ll go to work.  Her husband the type of job he has he can 
adjust his schedule a little bit so he’ll be there during the day while she goes to work and 
she goes home washes up goes to the hospital, spends the night at the hospital, gets up, 
and goes to work. 
 
Another participant focuses on the helplessness a family feels when a child with sickle cell 
disease is in pain.   
And the drain it takes on family members as parents to know something is wrong with 
your child and you’re helpless and what I see my girlfriend go through at times there is 
nothing she can do to ease the pain and discomfort. 
 
Childhood disease can cause tension and stress within a family as they try to manage caring for a 
child and maintaining jobs and other relationships.  Participants gained intimate knowledge of 
these strains from discussion with individuals who have a child with sickle cell disease.  Other 
social issues that were addressed by participants’ conversations focused on the stress an 
individual with sickle cell disease may experience as he/she interacts with the health care 
profession.  A woman describes the difficulty an adult may have acquiring pain medication from 
a skeptical physician in order to treat his/her sickle cell disease. 
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The other thing sometimes the medical profession is not very sympathetic and they think 
the young people want the drug and there is really no pain.  So there are a whole lot of 
things that are going on.  They think you just want some morphine drip.  Come on!  You 
want to be out doing things you want to do and being active just like your other friends 
but because you are in the hospital and they can’t pin point the pain its almost like back 
pain you can’t really pin point it. 
 
Additional participants spoke of social/personal strains on an individual with sickle cell disease 
when they miss school or work due to time spent in the hospital. 
Table 9. Knowledge of Sickle Cell 
Knowledge of Sickle Cell  
• Reliance on experience 
           - Symptoms 
           - Distinguish disease and trait 
           - Misconceptions/Uncertainty about inheritance 
           - Social issues 
 
5.2.5 BARRIERS TO EDUCATION AND AWARENESS OF SICKLE CELL DISEASE 
AND NEWBORN SCREENING 
Participants’ discussion revealed that there are a significant number of individuals who have 
inaccurate or incomplete information about sickle cell disease and newborn screening.  However, 
it was important to analyze conversation in order to determine why this is so.  Each focus group 
provided insight into the barriers that prevent an individual from acknowledging the presence of 
sickle cell disease in the community and the chance that a child could be born with the condition 
within his/her family, as well as, the barriers to accessing information.  The researcher 
categorized these barriers as personal, familial, and societal/cultural (Table 10).   
Themes identified as personal barriers include: fear, denial, and overwhelming 
responsibilities.  For some individuals, fear was used to describe inability to trust the medical 
 65 
establishment due to past abuses directed against African-Americans.  Participants discussed the 
Tuskegee syphilis study and eugenic attempts to eliminate African-Americans.  As one 
participant said, “Like the Tuskegee experiments, our parents pass that on to their children and 
grandchildren.  That’s don’t trust the police, don’t trust the medical that is passed on.”  
Participants did not feel that newborn screening for sickle cell is an attempt to discriminate or 
harm African-Americans, but the general fear of testing and medical professionals prevent 
individuals from going to the doctor and seeking information.  This distrust and fear was also 
evidenced in young focus group participants.  One young woman stated: 
I am praying on it because it is really crazy the way they use black people for 
experimentation and then they don’t teach you a dog gone thing in the schools about what 
is going on and it probably has to occur with the people…start speaking up and saying 
something. 
 
Fear also played a central role for some individuals who believed that if you think about disease 
it will happen to you or your family members.  A male participant stated: 
I believe in not worrying about something.  If you start thinking about these different 
diseases coming your way sooner or later it’s going to smack you right in the face.  I 
don’t deal with it.  When it happens, it happens.   
 
Another woman expressed a sentiment that was heard repeatedly during each focus group.  
“Sometimes people they don’t want to know.  They like to stay ignorant to the fact.  If I don’t 
know it, then it can’t hurt me.”  This fear certainly prevents individuals from acknowledging the 
risk for sickle cell disease in their families and communities and inhibits them from seeking 
information from health professionals.  The fear of disease is not specific only to sickle cell.  
One focus group attendee spoke of her experience with relatives who did not want to 
acknowledge the risk for polycystic kidney disease in the family.   
I have to be real strong even with the rest of the family.  This is something I have to do.  I 
have brothers and a sister.  ‘I don’t want to know.  I don’t want to know.’   But like I said, 
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I want to save my grandchildren.  I am trying to protect my grandchildren.  I was trying 
to protect my children.  It was not something that I went into.  I was forced into it. 
 
This fear of knowing about the increased risk for and even, at times, trying to avoid 
thinking about the risk appears different from the denial of facts that other participants spoke of.  
These participants described having an accurate knowledge of the risk for a particular disease in 
the family but openly denied its impact on their personal health.  A woman summarizes this 
barrier, “Even those things that the family has experienced, I don’t worry just because they 
experienced them.  Doesn’t mean me and mine are going to experience it.”  Another participant 
expresses this sentiment as a rejection of family history. 
Sometimes we take on different things that we hear and we accept and sometimes the 
doctors will impart things and make you believe that you are going to have this.  No I am 
not going to have this and I am not accepting what you are saying and I am not going to 
receive it.  My grandmother had that and yes my mother had that but that does not mean I 
am going to have that.  Now you may want me to have this but I am giving this back to 
you.  I am not having cancer.  I am not accepting diabetes, and I am not claiming it from 
this point on so I am giving it back to you. 
 
For this participant, it appears that accepting the risk for disease in the family would be too 
overwhelming and it is a self-preserving to deny the increased risk.   
A personal barrier for participants of all ages was the feeling of too many responsibilities 
and no time to be concerned about the risk for sickle cell disease.  In some cases, this could be 
characterized as avoidance behavior while for others it is an uncertainty about what questions to 
ask.  For young mothers, there was a sense that other daily challenges take precedence over 
thinking about newborn screening for sickle cell disease/trait.  This participant describes the 
overwhelming responsibilities and concerns of young mothers and the inability to focus on non-
pressing issues.   
I believe as a lot of our people have other things to worry about beside whether my kid 
has sickle cell.  There are other issues whether they are going to have food on the table, 
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whether their mother is a drug addict.  A lot of these kids are out there.  They are raising 
themselves because their parents are drug addicts.  They have other issues that are more 
important to them than this. 
 
When asked whether or not they are concerned about the risk of sickle cell disease in the family, 
several focus group participants also believed sickle cell disease is not a personal priority.  
Individuals made statements such as “I have too many other things.  I don’t even want to go 
there.”  As demonstrated by this participant, a feeling of no time to think about sickle cell may be 
avoidance behavior. 
 The absence of open communication about risk for disease is the primary family barrier 
to sickle cell disease awareness and education.  In general, participants believed that a feeling of 
shame prevents older relatives from sharing a history of sickle cell or any other disease.  In the 
following passage, a participant describes the breakdown in communication about health issues 
in her family.   
I’ll give you a for instance.  My dad is 82.  I just found out about a year ago that my dad 
is the oldest brother out of 6 siblings.  My cousin is doing a family history so he called.  
He is a radio announcer in Baltimore.  He said I’m going to do a family history and ask 
everybody what school they went to, who they married, and so forth.  So I asked my dad 
he said well you know one of my brothers has diabetes and my other brother has this and 
my sister has this but don’t tell them I told you so.  What I am saying is if his brothers 
and sisters have these illnesses and he doesn’t want me to know how are their children 
supposed to know.  How is this going to go down from generation to generation? 
 
Participants were aware that a lack of family discussion about risk for disease prevents future 
generations from making informed decisions about their health.  A participant shared the 
following, “I think a lot of times most families we don’t sit together to talk about family history 
and those things pass down from generation from ancestors and so once you learn your family 
history then you can have a better picture.”  There is also a positive belief among participants 
that families are improving communication. A participant expressed this opinion saying, “I think 
 68 
more families are talking more about it.  It’s not seen as you have to be ashamed about it.”  The 
shame and stigma of disease is decreasing as individuals come to understand the importance of 
knowledge and prevention.   
Focus group discussion illuminated the primary societal barrier to sickle cell education 
and awareness.  The central theme identified was a lack of awareness due to little media 
attention, minimal physician focus on the topic, and ignorance among the increasing number of 
teenage mothers.  Comments made by participants were striking for this lack of awareness in the 
community.   
Because you didn’t hear about it a lot anymore.  I hadn’t heard about sickle cell since 
what the 60’s or 70’s and knew people that I went to elementary school with and part of 
high school and middle school maybe that had it and they passed on many years ago in 
their 20’s or 30’s and you just didn’t hear about it anymore.  I thought maybe no one was 
getting it anymore. 
 
Other participants also believed that due to the lack of attention and their own lack of awareness 
on the topic of sickle cell that the disease prevalence had decreased or that a curative treatment 
had been developed.   
I think of people not being made aware of what sickle cell really is.  Before I became 
employed with the school, I hadn’t heard about sickle cell for many, many years and I 
thought wow it had passed on but I’m like wow it’s still alive and it’s still untreatable, 
incurable. 
 
This lack of awareness also led to sense of frustration and even anger for individuals who had a 
first encounter with the condition when a child was born with disease or trait.  The following 
comments are from a female participant who recently became the mother of a child with sickle 
cell trait.   
I didn’t know about it either until I had my son and they told me he had sickle cell, the 
trait, but it’s the fact that I never - I mean my husband is here - but I never heard of it 
either.  I could have had it.  He could have had it and we had kids and they could have 
had the actual sickle cell. 
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 Focus group conversation brought attention to the primary reasons why participants feel 
there is a lack of sickle cell awareness in the community.  First, participants explained the belief 
that there is not enough sickle cell disease activism and health education within the community 
and that leads to minimal media attention on the condition.  A male participant spoke of the 
absence of public health advertising needed to increase awareness in the community.   
I remember in the 80’s it was on billboards that is the first time I had heard about it.  I 
came back here from some place else and it was on billboards they had some celebrities 
on TV talking about it then after the 80’s you don’t hear about it anymore. 
 
Participants believe that other public health issues such as HIV/AIDS are given more media 
attention within the community. 
It’s (sickle cell) a disease that affects mostly African Americans and then I’ll bring this 
up.  AIDS affects everyone.  Every day, every time you can see radio, print, TV about 
AIDS and HIV ‘Get tested.’  How come nobody is out in the communities saying to 
African Americans put it (sickle cell) on TV.  It doesn’t matter whether it affects 
Caucasians or Mexicans or whoever.  Why isn’t it out there?  Like I said I didn’t know 
about it ‘til I was 30 something years old. 
 
Participants acknowledged the significance of preventing HIV/AIDS in the African-American 
community but feel that sickle cell disease is also a health condition which can be impacted by 
media attention and campaigns to increase awareness and decrease prevalence. 
What I’m saying is that they are paying millions of dollars for commercials like herpes is 
the greatest thing to have.  If you have it they are spending money on things like that that 
people can prevent.  Of course you have to put the awareness out there about HIV but 
how are you getting it?  I am saying for the imperfections that we all inherited put that 
out there too cause you don’t know it’s out there. 
 
Individuals recognize the lack of awareness in the community as a whole and would like to have 
more attention given to sickle cell in the media. 
 Participants believe that a lack of awareness also stems from physicians not providing the 
necessary information about sickle cell.  Throughout the conversations, participants expressed 
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their frustration with their lack of knowledge and felt that their physician should have supplied 
the information regardless of whether or not the patient asked about carrier testing.  In many 
cases, participants believed discussion about sickle cell should occur at the same time as other 
conversations with their physician regarding family history and risk for multifactorial conditions 
such as hypertension and diabetes. 
You go in the doctor’s office waiting for him.  You see ‘If you have diabetes, take your 
socks off and shoes.’  You see mammograms.  You see all these different things on the 
wall.  There are flu shots.  I don’t see anything about sickle cell.  I don’t see anything 
about lupus.  I see more about stem cell research which I have no clue really what it is but 
I see a lot of it and bone marrow transplants for African Americans cause that is so rare.  
If it only affects a certain group of individuals be it minorities, then it seems like there is 
not a lot of information out there and they (physicians) don’t care. 
 
There was a strong feeling among the focus group participants that when a patient does not have 
awareness of sickle cell disease risk it is important for the physician to ask questions and provide 
them with the appropriate information.   
 The sentiment of the need for physicians to educate patients was also expressed when 
participants discussed the lack of sickle cell awareness among young mothers.  One woman 
stated: 
Mothers are not physicians and so you can’t expect them to be informed and know what 
questions to ask and so I think if you are a professional concerned physician then you will 
supply that kind of information to them and particularly young mothers.  Girls are having 
babies at 11 and 12, 15, 18 years old they don’t have any questions to ask they don’t 
know and so it’s the responsibility of the physician. 
 
Participants felt that teenage mothers are ignorant of the risk for sickle cell disease and therefore, 
healthcare providers must guide these young women, ask questions about family history, and 
take the time to explain sickle cell disease and trait. 
I think also with mothers being so young today they are not aware.  What do they know 
about sickle cell?  Adults don’t know about it.  With the age of the mothers being so 
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young, they don’t know and a lot of times the doctors they take advantage of that and 
they may just mention it but it will blow over.  This is a young mother.  She is probably 
concerned about how am I going to take care of this child - fearful and frightened.  So 
doctor probably knows that but that parent doesn’t really focus on that. 
 
The young mothers are inexperienced with what questions need to be asked when speaking with 
the doctor and participants strongly believed that physicians need to take the time to have a 
conversation about sickle cell and carrier status.   
Table 10. Barriers to Awareness and Education of Sickle Cell and Newborn Screening 
Personal Family Societal 
• Fear 
• Denial 
• Overwhelming 
responsibilities 
• Absence of open 
communication 
• Too little media 
attention 
• Minimal physician 
discussion 
• Ignorance among 
increasing number 
of teenage mothers 
 
5.2.6 IMPROVEMENTS TO COMMUNICATION ABOUT SICKLE CELL AND 
NEWBORN SCREENING 
Participant discussion stimulated suggestions of how to improve awareness about sickle cell and 
improve communication about newborn screening.  Participants were enthusiastic when making 
suggestions of how to expand access to information for members of their community.  Their 
suggestions included holding community discussion groups, involving the church in information 
dissemination, increasing public health messages using the media, developing school programs 
focused on inheritance and sickle cell, and adding a sickle cell trait status question to the family 
history questionnaire provided by physicians (Table 11).  At the conclusion of each focus group, 
participants were excited to continue the conversation about inheritance and sickle cell with 
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other community members.  Many mentioned holding further discussion groups at the Kingsley 
Association where they could feel comfortable asking an expert.   
That is what is missing in our community all discussions about vital issues critical issues 
so this is a real important thing is because we got to talk to each other we have to discuss 
things so this is very good.   
 
Participants also pointed out that conversations about prenatal testing, newborn screening, and 
family history need to occur at churches as well.  Individuals felt that these topics involve moral 
issues which impact the family and are best discussed in the church.  Several participants wanted 
to see increased use of the media in the sickle cell public health campaign.  Suggestions included 
commercials and billboards.  None of the focus group participants mentioned knowledge of the 
current project developed by the Sickle Cell Program at Children’s Hospital of Pittsburgh that is 
targeted at sickle cell education in public schools or the Murray-Irvis Sickle Cell Society of 
Pittsburgh.  However, when making suggestions participants described the need for such a 
program aimed at young people and educators.   
I think someone needs to come out to the school district to let the people know sickle cell 
is still alive, it is still incurable disease, and we are still working.  I don’t know how many 
agencies are involved in working on sickle cell but you don’t even hear about that 
anymore with foundations.  People need to be made aware that sickle cell is in children.  
You have it here in your school.  People need to know.  They need to be made aware. 
 
Focus group participants also wanted to add a question about personal sickle cell trait status and 
family history of sickle cell to current medical questionnaires completed at the physician’s 
office.  They believed this would encourage physicians to discuss the topic with their patient 
and/or stimulate the patient to ask the physician questions about sickle cell.   
Participants were adamant that awareness of sickle cell would improve if a physician 
communicated the information with compassion, empathy, and patience.  One woman spoke of 
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her frustration with doctors who do not give of their time to listen to patient concerns.  “No one 
has the time I mean these doctors come in and look at you.  They are not in there a good five or 
ten minutes while you are thinking of something to ask they are on their way out and you’re like 
wait a minute.”  Another participant responded to her comment by stating, “That’s why I stayed 
with the doctor I’m with.   She pulls up a chair and sits down.”  For these individuals it was 
important to receive information about sickle cell and newborn screening from a physician they 
have a relationship with.   
It’s that piece of mind just knowing that all you got to do is get on the phone or go and 
say this, this, and this and you know you are going to be taken care of.  You know you 
are going to be talked to like you are a person.  They got your interest at heart with them 
that means so much to a person especially when you are hurting. 
 
Individuals appreciated communicating with their obstetrician about newborn screening due to 
the familiarity and the established relationship.  “Obstetrician - cause during the pregnancy 
because you are relating to them and they know a lot about it (newborn screening).”  For these 
participants, it was more important to hear the information in the prenatal period by the 
obstetrician because of this relationship and not because of the hectic time period after the birth.   
Participants also recognized that it is important to ask questions and independently seek 
information.  “My PCP, I’ll call her.  We’ll talk.  We have a very close relationship and then 
from there I’ll start my research I’ll go out to the internet.”  When a patient is informed, it 
improves communication and the relationship with the health professional.   
I am my most prized advocate I am very, very informed and very knowledgeable and I 
know that I need to be informed and knowledgeable so that whatever is wrong with me I 
am an informed partner with my PCP and together we discuss my treatment and my 
treatment options. 
 
Participants acknowledged that communication cannot be a one-sided process.   
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Table 11. Improvements to Communication about Sickle Cell and Newborn Screening 
Increase Awareness 
• Community discussions 
• Church involvement 
• Increase media messages 
• Adding sickle cell question to physician questionnaires 
• Acknowledging importance of physician-patient relationship 
• Developing school sickle cell programs 
 
5.2.7 APPROACHES TO DECREASING SICKLE CELL DISEASE PREVALENCE 
Focus group participants had the belief that increased awareness of sickle cell disease in the 
community will lead to greater family communication and ultimately, lower rates of sickle cell 
disease.  Participants believed that family discussion will lead to more informed choices for 
future generations.  In the following passage, a woman discusses her hope that by telling her son 
he has sickle cell trait he will think through his selection of a spouse/partner.   
I first found out that my oldest son was a sickle cell trait and I was told at that time and 
by them talking let me know that they explained to me at that particular time that he had 
to be very careful who he had kids by.  He had to make sure that person was not a trait 
too and I’ll tell you something that is something else that I had to, you know, like when 
they talked about getting married going with the traits and stuff because I told them you 
don’t want to have it if you can prevent it.  You don’t want to have a sick child like that.  
I mean if you are going to be a trait and your mate is a trait and you both know that then 
at least you can say well we choose not to have children and choose not to let that to have 
a sick child.   
 
Intertwined with this desire to open communication in families and to allow informed decisions 
is a belief that the chance to have a child with sickle cell disease will lead to great fear.  
Participants believe that this fear will cause a couple who both have trait to choose not to have 
children.  A participant mentions a friend who is unwilling to continue taking the risk of having a 
child with sickle cell disease, “I had a girlfriend who said both her and her husband have the 
trait.  They have two kids and they are stopping.  They don’t want to risk it.”  Another participant 
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discusses how she would not have had children if she was aware of a genetic condition in her 
family. 
If somebody talked to me about genetic stuff when I was young, you wouldn’t have to 
worry about my legs being closed because they would have stayed closed.  I mean 
seriously some things you don’t want to be responsible for passing on to your children.   
 
Participants also believed that exposing young people to families with a child who has sickle cell 
disease or allowing young adults to speak with a person who has sickle cell disease would cause 
them to think about their own trait status and reproductive decisions. 
It’s like you have to see it.  This is real.  Look at these children that are in the hospital. 
Look at these parents getting up at 4 in the morning.  They are missing work.  It’s the 
grace of god that the father has a job where they are understanding and the mother 
essentially works part time because her time is going back and forth to the hospital that 
has to be a part of the reality when you do a round table discussion.  Bring a child in with 
sickle cell and let them hear what they go through because it brings more meaning.  ‘I 
don’t know what I am going to eat tonight.’  Well you know what?  How would you like 
to not know what you are going to eat tonight, not know if you are going to have a job 
tomorrow, and not know if you are going to get up at 2am to take your child to the 
hospital because they are sick again.  That is a reality.  So I would rather deal with ‘I 
don’t know what we’re going to eat tonight’ but ‘I know I took the time out to make sure 
genetically you didn’t have the trait and even though I have the trait, we are going to have 
a healthier child.’ 
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6.0  DISCUSSION AND CONCLUSIONS 
The specific aims of this study were to assess African-American community members’ attitudes 
and beliefs regarding sickle cell disease and trait, prenatal testing, and newborn screening.  
However, the overarching goal of the project was to characterize the barriers to education and 
awareness about sickle cell and newborn screening in order to determine if a community based 
intervention project could be developed to improve knowledge of these topics.  Qualitative 
methodology was pursued to explore these subjects in the African-American community of 
Pittsburgh and to understand the perspective of the people the intervention project would serve.  
It is the belief of the researcher that the contribution of this study is not only in the analysis of 
what African-American community members do and do not know about genetics, newborn 
screening, and sickle cell but to understand why the majority do not have a familiarity with these 
topics and to determine if an intervention could be developed to improve education and 
awareness. 
This study included the opinions of 35 individuals of African-American and/or mixed 
ancestry who reside in the Pittsburgh communities surrounding the Kingsley Association of East 
Liberty.  The individuals who participated in this research project were self-selected and many 
spoke of the importance of giving back to the Healthy Black Family Project by contributing their 
time to research.  Of the 35 participants, the majority (74%) are members of the Center for 
 77 
Minority Health’s Minority Research Recruitment Database and therefore, already inclined to 
partake in research.   
Pre-discussion survey results characterized the demographics of focus group participants.  
Approximately 91% of participants are female.  This percentage is comparable to the statistics 
collected on gender by the Family Health History Initiative of the Healthy Black Family Project.  
Of the 420 individuals who have completed their family health history, 83% are female.  
Unfortunately, the uptake of HBFP services by African-American men has been low, and the 
recruitment of the current study is reflective of the gender gap seen in the larger project.  
However, the Family Health History Initiative is currently developing methods to reach out to 
the male population.  Studies examining the barriers to African-Americans’ participation in 
research have demonstrated that men and women differ in the types of barriers described and the 
impact those barriers have on participation (BeLue, 2006; Hoyo, 2003).  Specifically, African-
American men in qualitative studies have stated that they are concerned about the costs and time 
commitment of research participation (BeLue, 2006; Hoyo, 2003).  Additionally, men have been 
found to have a low interest level and participation rate in research because of a lack of 
knowledge and awareness about the process of research (Hoyo, 2003).  In contrast, African-
American females have described barriers such as the researcher-participant relationship and the 
need to have the researcher make the participant feel comfortable (BeLue, 2006).  These barriers 
could be contributing to the current study where the majority of participants are female.  Women 
may have felt more comfortable than men attending the focus groups because they had 
previously met with the researchers and are familiar with the Healthy Black Family Project and 
Kingsley Association.  Male participation may have been negatively impacted by the two hour 
time commitment advertised for the focus groups. 
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The median age of focus group participants is 57 years with a range of 26-77 years of 
age.  Though discussion of topics such as newborn screening and prenatal testing may be more 
appropriate for individuals of childbearing age, the overall goals of the project were attained by 
capturing the opinions of diverse members of the community.  It is also important to point out 
that as evidenced by group conversation sickle cell disease pervades community life regardless 
of age.  Many of the older focus group participants are primary caretakers for grandchildren and 
had intimate knowledge of prenatal testing, newborn screening, and sickle cell.   
The 35 participants who comprised this research study are representative of the 
household income level of the Health Empowerment Zone but have a higher level of education.  
The majority or 32% of focus group participants have a household income between $20-35,000 
and 56% have a household income between $10-35,000.  Data collected by the US Census in 
conjunction with information compiled by the Center for Minority Health (CMH) and the 
Allegheny Health Department has shown that the median household income within the Health 
Empowerment Zone is $26,167 with 27% falling below the poverty level (Robins, 2005).  The 
2005 US poverty threshold for a family of four with two children under age 18 is $19,806 and 
the poverty level for a family of two with no children is approximately $13,000 (US Census 
Bureau, 2005).   
Data collected by CMH and the Allegheny Health Department has also shown that 
approximately 81% of individuals living in the Health Empowerment Zone are high school 
graduates (Robins, 2005).  In the current study, 100% of participants completed high school with 
72% completing post-high school education.  The difference in educational background between 
focus group participants and those living in the Health Empowerment Zone indicates that this 
sample of individuals is not representative of the larger African-American population.  
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Importantly however, this study was able to demonstrate that a sample of middle class and 
working poor African-Americans with a high level of education has both inaccurate and 
incomplete information about newborn screening and sickle cell.  Therefore, one could infer that 
a sample of African-Americans who more closely resemble the population living in the Health 
Empowerment Zone would have even less accurate knowledge of these topics. 
The current study found that a majority of focus group participants do not know their 
personal sickle cell trait status or that of their spouse/partner and children.  A previous study 
surveying 147 African-Americans demonstrated that 31% know their personal trait status while a 
survey of 282 African-Americans in a large metropolitan area of California identified that only 
15.9% know if they are a carrier for sickle cell (Midence, 1994; Wright, 1994).  This research 
project has shown that 42% of the 35 participants know their own sickle cell trait status.  This 
percentage is higher than expected, but given that 97% of participants have health insurance and 
only 17% have difficulty seeing a physician due to cost, individuals may have greater interaction 
with the medical profession and access to carrier testing for sickle cell.  The large percentage of 
participants with knowledge of their personal sickle cell trait status may also be due to their age.  
The majority of focus group participants experienced their childbearing years during the early 
1970s which is the time period when federal funding and state sickle cell screening programs 
were offered (Markel, 2006). 
Interestingly, of the 27 focus group participants with a spouse or partner only 26% know 
that individual’s sickle cell trait status.  This figure emphasizes the theme which emerged from 
focus group discussion regarding the lack of family communication about health conditions.  Of 
the 82% with children, only 40% of participants know their child’s sickle cell trait status.  This 
may be reflective of the fact that many participants are past their childbearing years, and 
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newborn screening for sickle cell did not become mandatory in Pennsylvania until 1990 (Olney, 
2000).  As participants indicated throughout focus group discussion, parents of older children 
may not have known to ask their physician to perform carrier screening due to a lack of 
awareness of the risk for the condition.  Additionally, physicians may not have explained the 
importance of sickle cell carrier screening to their African-American patients. 
Analysis of focus group transcripts demonstrates that participants fall into one of three 
knowledge categories when discussing genetics, prenatal testing, newborn screening, and sickle 
cell.  These categories are those who are unaware, those who have accurate but incomplete 
knowledge, and those who are misinformed.  Unfortunately, all of these categories indicate that 
the current work to educate individuals about newborn screening and sickle cell is not sufficient.  
There were many individuals who had pieces of the larger issue when discussing each of these 
topics.  However, amidst each statement indicating accurate knowledge were statements where 
participants held an inaccurate view or had no information to contribute to the discussion.  For 
example, participants had an accurate understanding of the symptoms and clinical course of 
sickle cell disease but in general were misinformed about the autosomal recessive inheritance of 
the condition.  Individuals accurately identified that sickle cell trait and disease travel through 
families but did not understand the risk to children conceived by parents where one or both are 
sickle cell carriers.  These findings support the work of Treadwell et al. who also found 
significant misconceptions among African-Americans about the inheritance pattern of sickle cell 
in various family scenarios (2006).  When discussing newborn screening, there were a significant 
number of participants who indicated they are unaware that such a program exists.  Focus group 
work in the community setting by Catz et al. identified a similar lack of awareness about 
newborn screening (2005).  However, in the present study there were also many participants who 
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inaccurately believed newborn screening was testing performed to determine if a baby had 
jaundice, prenatal drug exposure, or other non-genetic health conditions.   
During analysis of focus group transcripts, it was interesting to witness the impact of 
providing brief genetics education on the flow and topics of conversation.  For those individuals 
who did not have an understanding of newborn screening or prenatal testing, it was important for 
the moderator to share a definition so that conversation could proceed.  This small amount of 
education stimulated focus group discussion and allowed individuals to debate the risks and 
benefits of prenatal testing and newborn screening and to articulate the issues which impact the 
community.  After individuals determined the differences between prenatal testing and newborn 
screening, they were able to deliberate the benefits of having knowledge in the prenatal period 
versus after birth.  In the prenatal period, participants described the benefit of having genetic 
information so that they were aware of the risks and could make choices about continuing or 
terminating a pregnancy.  For newborn screening, benefits of knowledge were for treatment and 
preparation.  The theme of preparation as a benefit of newborn screening was also identified in 
focus groups conducted by Catz et al. 2005 and Laskey et al 2003.  Interestingly, individuals in 
the current study could articulate not only the procedural risks of prenatal testing such as 
miscarriage, but the risks to the family relationship and individual mental health when genetic 
information is learned.  However, newborn screening was viewed as only beneficial with no risks 
or downfalls to having this type of genetic knowledge.  This may be due to participants’ less 
sophisticated knowledge of newborn screening when compared to prenatal testing. 
As African-American participants attempted to make sense of complicated issues such as 
genetic disease and genetic testing in the prenatal or newborn period, the theme of reliance on 
experience was expressed.  When discussing the resources participants access for genetics 
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information, very few individuals spoke of seeking out information from the library, books, or 
internet resources.  Similarly, a quantitative study by Nicholson et al examining the relationship 
between race and women’s use of health information resources found that African-American 
women had 50-70% less odds of using print news media, computer resources, or health 
organizations for information when compared to Caucasian women (2003).  Instead of these 
traditional sources, focus group participants relied on what they knew from on the job 
experience, participation in research studies, stories they had witnessed on television, and 
discussions with physicians, family, and friends.  Similarly, when participants described the 
symptoms and inheritance of sickle cell disease they alluded to observations of children, adults, 
and families with sickle cell disease and how the condition impacts daily life.  Research on the 
information seeking behaviors of African-Americans has demonstrated the theme of the 
importance of personal sources such as family, friends, and the church (Nicholson, 2003; 
Talosig-Garcia, 2005).  Nicholson et al demonstrated that African-American women are more 
likely than Caucasian women to report family/friends and the church as useful health information 
resources (2003).  Focus group participants in the current study relied on familiar sources and 
past experiences to explain their attitudes and beliefs on a topic and spoke confidently regardless 
of whether or not the information they shared was accurate.   
Focus group participants also expressed the theme that familiarity increases the ability to 
trust.  For example, participants spoke of a reliance on friends and family who had an affiliation 
with the healthcare profession as a resource for genetic and other health information.  This 
familiarity allowed them to converse with great ease and trust and therefore, rely on that 
particular individual as a primary resource for health education.  Participants also valued the 
familiarity and relationship with a personal physician.  Similar to the findings of Treadwell et al. 
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2006, participants believed that in order to be receptive to what the physician is communicating 
there must be a mutual respect and established relationship between physician and patient.   
In addition to the importance of the physician-patient relationship in the 
communication/education process, focus group participants identified specific personal, familial, 
and societal barriers to awareness that are at work in their family and community lives.  The 
personal barrier described as fear and distrust of the medical profession due to past abuses is an 
issue deeply rooted in the African-American culture.  The theme of distrust of the medical 
profession emerged in focus groups conducted by Treadwell et al and Zimmerman et al as well.  
Additionally, a qualitative study of African-American community attitudes toward medical 
research found that the Tuskegee syphilis study was an important negative factor in the decision 
to participate in research for older individuals while distrust of physicians was a personal barrier 
for both younger and older participants (Hamilton, 2006).   
Participants also feared acknowledging the risk for a health condition like sickle cell to 
occur.  Many individuals believed that simply by thinking about a risk it would cause the disease 
to develop in themselves or a family member.  This magical thinking was an interesting 
disconnect among participants determined to have a high level of education in comparison to the 
general population of the Health Empowerment Zone.  This fear led to denial or rejection of 
family history for some participants.  African-Americans’ denial of multifactorial health 
conditions has been documented in the literature.  Specifically, denial has been associated with 
diseases which have a significant racial health disparity such as prostate cancer, heart disease, 
breast cancer, and stroke (Gullatte, 2006; King, 2001; Richardson, 2004; Rucker-Whitaker, 
2006).  These studies have demonstrated themes of anxiety and repression of fear which leads 
African-Americans to deny their risk for disease (Gullatte, 2006; King, 2001; Richardson, 2004; 
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Rucker-Whitaker, 2006).  A study by Gullatte et al documented this denial as “’If you name it, 
you claim it’” (2006).  This sentiment is similar to the feeling expressed in the focus groups of 
the current study that if you think about a disease it will happen.  It is difficult to determine the 
cause for such a belief in this sample of African-Americans.  However, the presence of multiple 
individuals in each of four focus groups who expressed this opinion indicates that it may be part 
of a larger cultural belief system.   
It is important to examine the connection between the barriers of fear, denial, and a 
societal/cultural lack of awareness with the absence of open communication within African-
American families.  Participants stated they are limited in their knowledge of family disease risk 
because older generations do not want to discuss a personal or family history of health 
conditions.  Issues of personal and family shame prevent relatives from discussing their health 
and the risk to develop disease.  Participants also brought attention to the lack of family 
conversation about sickle cell trait status and history of sickle cell disease.  They believe the 
absence of discussion causes future generations to have misconceptions about sickle cell that 
lead them to fear and deny their family history.  The absence of family communication about 
sickle cell is also a factor in the ignorance among teenage parents.  Participants stated that if 
parents never talk with their children about sickle cell trait status and the risk for disease then a 
lack of awareness is perpetuated into the next generation.   
6.1.1 RECOMMENDATIONS  
To address these barriers to education and awareness of sickle cell and newborn screening, it is 
essential to design an intervention which is nested within the larger Healthy Black Family 
Project.  The Healthy Black Family Project has become enmeshed in Pittsburgh’s African-
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American community as it allows participants the opportunity to learn about health and make 
lifestyle changes with the support of the community.  Within this framework, an intervention 
targeted at improving awareness about sickle cell disease would build upon the trust and rapport 
which has already been established with the community.  Additionally, a sickle cell intervention 
could be implemented alongside other health promotion programs to allow participants the 
opportunity to learn and interact in a familiar community environment.   
Based on the information gathered from this study, it is essential to continue the health 
education mission of the Healthy Black Family Project and to design interactive programs where 
participants can learn from experience.  Guest speakers from the local community such as 
families who have a child with sickle cell disease should be invited to the Kingsley for 
community conversation.  Therefore, adults and children can freely ask questions which they 
would not otherwise ask a speaker from outside the community.  The personal story of the family 
and the individual with sickle cell would provide participants with the experience and 
observation to draw on as they attempt to understand the condition and explain it to other family 
members and friends.   
The Family Health History Initiative should continue and expand to reach more families 
within the African-American community in order to provide individuals with an accurate 
assessment of disease risk and tools to open discussion about health within the family.  During 
meetings with the genetic counseling student, participants should be specifically asked about 
their personal sickle cell trait status and family history of sickle cell trait/disease.  If an 
individual has a family history of sickle cell trait/disease, the genetic counseling student can then 
provide education about the inheritance of the condition, the differences between disease and 
trait, and specific questions to ask a physician about carrier screening and sickle cell disease.   
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The Healthy Black Family Project also has the potential to extend the reach of its media 
work to include public health messages about sickle cell disease and create literature to be 
disseminated at health fairs, churches, and community clinics.  Participants’ concerns about the 
lack of sickle cell awareness among young parents and single teenage mothers are also valid.  
Therefore, interactive programs targeted at youth and young mothers should be developed to 
provide education on genetics, sickle cell, and other health topics.  Currently, the 
Hemoglobinopathy Program of Children’s Hospital of Pittsburgh is developing sickle cell 
education programs for young people in the Pittsburgh public school system.   
In summary, a community approach to prevention needs to be implemented to address 
this community health problem.  The Center for Minority Health and the Healthy Black Family 
Project in conjunction with the Hemoglobinopathy Program of Children’s Hospital of Pittsburgh 
are in a unique situation to provide such an intervention and improve awareness and education 
about sickle cell disease.  The Center for Minority Health has the framework in place to address 
sickle cell at the community level in the same way as they have so tirelessly worked to alleviate 
the burden of multifactorial disease in Pittsburgh’s African-American population.   
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APPENDIX B: SUBJECT RECRUITMENT 
B.1 FLYER ADVERTISEMENT 
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A HEALTHY BLACK FAMILY  
PROJECT RESEARCH STUDY 
 
Participate in a Focus Group on Genetic 
Testing and Screening 
 
We value your opinion. 
 
Brought to you by: 
Center for Minority Health of the Graduate School of Public Health 
University of Pittsburgh 
 
Share your opinions on topics related to genetic testing and screening in 
small focus groups at the Kingsley. 
 
Participate in the focus group and receive a $25 gift card to Giant 
Eagle and refreshments. 
 
Call Katie or Leah at 412-383-9822 for more information or to 
schedule a focus group. 
 
Must be 18 & over and willing to commit approximately 2  
hours of your time. 
 
Principal Investigator: Stephen B. Thomas, PhD 
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B.2 TELEPHONE RECRUITMENT SCRIPT 
Telephone Contact (Individuals who have completed family history) 
Hello, my name is Katie Hoffman from the Healthy Black Family Project.  I met with you at the 
Kingsley in (month) to draw out your family history.  I was calling to invite you to participate in 
a research study that I will be conducting.  This research study will be in the form of a focus 
group.  A focus group is where several people come together to discuss a specific topic and share 
their opinions.  I am interested in hearing the opinions of African-American community 
members on the topic of newborn screening for sickle cell disease and I would like to hear your 
thoughts about this topic.  I hope to collect these opinions to help improve how information is 
transmitted to new parents about their child’s sickle cell status.  The groups will take place at the 
Kingsley and will take about 2 hours of your time.  During this group, you will be asked to share 
your thoughts and opinions on specific topics and questions posed to the group.  This research 
study will only be open to members of the Healthy Black Family Project.  There are some 
possible risks with this research such as familiarity with other participants in the group which 
could cause discomfort in sharing your opinion.  Your name will not be used to identify your 
responses, but there is a small risk of breach of confidentiality due to the audio recording of the 
session.  These recordings will be kept in a locked file drawer at the Center for Minority Health 
and then destroyed upon the completion of this study.  To thank you for your participation, we 
would like to offer some refreshments during the group and a $25 gift card to Giant Eagle.  Your 
participation is voluntary and you can withdraw your participation at any time.  Would you be 
interested in attending the group and offering your opinions?  If you have any questions about 
this research, please contact me at 412-383-9822. 
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B.3 PARTICIPANT LETTER 
Date 
 
 
 
Dear Name, 
 
The Center for Minority Health at the University of Pittsburgh would like to thank 
you for agreeing to participate in the focus group on Genetic Testing, Screening, and 
Research.  We value your opinion and we are very excited you will be joining us for 
our small group discussion about topics related to research, genetic testing, and 
genetic screening.  This letter serves as a confirmation for your scheduled focus 
group.  Please contact Katie Hoffman or Leah Slattery if you will not be able to attend 
your meeting or have any questions.  
 
  
Date:   
 
Time:  
 
Location:   The Kingsley Association 
6435 Frankstown Avenue  
Pittsburgh, PA 15206 
 
Contacts:  Katie Hoffman and Leah Slattery 
 412-383-9822 
 
Sincerely, 
     
 
     
Katie Hoffman, BS      Leah Slattery, BS 
Graduate Student      Graduate Student 
Center for Minority Health     Center for Minority Health 
412-383-9822      412-383-9822 
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APPENDIX C: MODERATOR’S GUIDE 
I.   Introduction (10 minutes) 
A. Good afternoon/evening and welcome to our session. Thank you for taking the time to join  
our discussion on sickle cell and newborn screening. My name is Katie Hoffman and I am with 
the Healthy Black Family Project from the Center for Minority Health at the University of 
Pittsburgh.  Assisting me is Leah Slattery who will be taking notes on the conversation during 
the focus group.  Please begin by filling out the survey in front of you by circling your answers.  
We will begin when everyone has completed this form. 
 
You have been invited because you are a member of the Healthy Black Family Project and your 
opinions on sickle cell and newborn screening are important to us. Our research team is trying to 
understand the attitudes and beliefs of African-Americans toward newborn screening for sickle 
cell disease.  We would like to hear your opinions in order to determine how information can be 
better provided to new parents in your community about sickle cell and newborn screening.  We 
need your input to make future newborn screening for sickle cell in Pittsburgh successful. We 
will ask you a number of questions and we need your honest thoughts and ideas. Please feel free 
to share your point of view especially if it is different from what others have said. There are no 
wrong answers, only different points of view. 
 
Now, let me share some ground rules. We want to make sure that everyone feels comfortable 
expressing his or her own opinion. We ask that you are respectful of everyone by listening to one 
another and waiting until the person speaking has finished before you begin. Please do not have 
side conversations with your neighbor during the discussion. All of your comments are helpful 
and would provide us with useful information. We have placed cards on the table in front of you 
to help us remember your names during the focus group. 
 
As you have probably noticed, we have a microphone on the table. We will be tape recording our 
discussion so that we don’t miss any of your comments. To assure you of your confidentiality, 
we will only be using the names you selected for today and will not use any names in our final 
reports. 
 
The group discussion will last about 2 hours, so feel free to enjoy your meal as we begin.  We 
will have a 10-minute break and restrooms are located near the gym on the first floor.  You 
should have already completed the brief survey and we will collect it before we begin. 
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II. Assessing Knowledge of Genetics 
 
Question 1 
 Where do you receive trusted medical information? 
Probe: From a Physician, Nurse, Pharmacist, Friend/Family member, TV, 
radio, newspaper, internet, seminar, etc.? 
  Probe: Why is this your most trusted source of medical information? 
 
Question 2 
 What comes to mind when you hear the word “genetic” or “genetics”? 
  Probe: Where have you heard this word?  Who has used the word? 
Probe: How do you think “things” are passed down to or inherited from 
one generation to another? Why? 
 
III. Assessing Knowledge of Prenatal Testing and Newborn Screening for Genetic 
Conditions 
 
Question 3 
When you hear the words “prenatal testing” what does it mean to you? 
[Definition shared if no one answers: Prenatal genetic testing is testing performed 
on the developing baby while a woman is pregnant.  It can be used to gather 
information about genetic health conditions in the baby.] 
Probe:  Are there benefits of prenatal testing? Why? 
Probe: Are there risks of prenatal testing? Why? 
 
Question 4  
What are some reasons it would be helpful to know a child has a genetic condition 
before leaving the hospital? 
 
Question 5 
When you hear the phrase “newborn screening” what do you think of? 
  Probe: Where have you heard the phrase used? 
  Probe: Who has used it? 
  Probe: Under what conditions or circumstances has it been used? 
 
IV. Assessing Importance of Newborn Screening 
 
Question 6 
Sometimes newborn babies are stuck in their heel to draw a small amount of 
blood for testing.  Please tell me what you know about this type of test?  
Probe: Why do you think it is necessary? 
 
Question 7 
 What kind of information would you like to know before a child’s blood is taken? 
  Probe: Who would you want to tell you? 
  Probe: When would you like to be told that information? 
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Probe: How would you want to receive that information (in print, face-to-
face, video)? OR Would you like to receive it from some other source? 
 
V.  Assessing Understanding of Sickle Cell Disease 
 
Question 8 
Please tell me what you know about the condition called sickle cell.   
Probe: (If they mention sickle cell disease and trait) What is the difference  
between the two? 
Probe: Do you think one is more serious than the other?  How? 
  Probe: How does someone get sickle cell? 
 
VI. Assessing Perceived Risk of Sickle Cell 
 
Question 9 
Earlier we talked about how things are inherited or genetics. Do you think there is 
a risk in your family for a future child with sickle cell trait?  Do you think there is 
a risk in your family of a future child with sickle cell disease? 
Probe: Why or why not? 
 
VII. Assessing Opinions on Transmission of Sickle Cell and Newborn Screening 
Information 
 
Question 10 
Scenario: It is three days after the birth of your child and you just found out your 
child has sickle cell disease.  How helpful would this information be to you? 
 
What if your child had sickle cell trait?  How helpful would this information be to 
you? 
 
Question 11 
What is the best way for new parents to receive information about newborn 
screening for sickle cell? 
 Probe: When should this information be provided? 
 Probe: Who should provide this information? 
 Probe: Under what conditions should this information be provided? 
Question 12 
What information do you think is important for parents to know about newborn 
screening? 
 
Question 13 
How can the community help new parents understand information about sickle 
cell? 
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VIII. Closing 
 
A. Thank you for your time and energy given to this discussion!  It was a pleasure  
listening to your thoughts and opinions.  We will need your signature to indicate you 
have received your $25 gift certificate to Giant Eagle before you leave. 
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APPENDIX D: SURVEY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 98 
We thank you for participating in this focus group. This survey is to gather information about the 
community’s interactions with sickle cell.  If there is a question that you do not feel comfortable 
answering, you can skip it and continue on.  Please answer the following questions to the best of your 
ability.  The survey should take approximately 10 minutes.  We would like to thank you in advance for 
your willingness to participate in this study. 
 
Section 1:  General Information 
 
1) What is your age? 
__ __ age in years 
 
2)  What is your gender? 
1 Male 
2 Female 
 
3) Are you Hispanic or Latino? 
1 Yes 
2 No 
3 Don’t know 
 
3a) Which one or more of the following would you say is your race?  (Check all that apply) 
1 White 
2 Black or African American 
3 Asian 
4 Native Hawaiian or Other Pacific Islander 
5 American Indian, Alaska Native 
6 Other [specify] __________________________ 
 
4) What was the total household income from all sources last year? 
1 Less than $10,000 
2 Between $10,000 and $20,000 
3 Between $20,001 and $35,000 
4 Between $35,001 and $50,000 
5 Between $50,001 and $75,000 
6 Greater than $75,000 
 
5) What is the highest grade or year of school you completed?   
1 Grades 8 or less (Elementary) 
2 Grades 9 through 11 (Some high school) 
3 Grade 12 or GED (High school graduate) 
4 College 1 year to 3 years (Some college or technical school) 
5 College 4 years or more (College graduate or post-graduate) 
6 Graduate level (Masters or PhD) 
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6) How would you rate your knowledge on genetics? 
1 Excellent 
2 Very good 
3 Good 
4 Fair 
5 Poor 
 
7) How would you describe your general health? 
1 Excellent  
2 Very good  
3 Good  
4 Fair  
5 Poor  
 
8) Do you smoke? 
1 Yes 
2 No 
 
9) How would you describe your weight? 
1 Underweight 
2 Healthy weight 
3 Overweight 
4 Obese 
 
10) Do you have one person you think of as your personal doctor or health care provider? 
1 Yes, only one 
2 More than one 
3 No 
4 Don’t know / Not sure 
 
11) Was there a time in the past 12 months when you needed to see a doctor but could not 
because of the cost? 
1 Yes 
2 No 
3 Don’t know / Not sure 
 
12) Do you have any kind of health care coverage, including health insurance, prepaid plans such 
as HMOs, or government plans such as Medicare? 
1 Yes 
2 No 
3 Don’t know / Not sure 
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Section 2: Sickle Cell and Newborn Screening 
 
13) Do you know your sickle cell trait status? 
1 Yes 
2 No 
3 Don’t know 
 
14) Do you know your partner/spouse’s sickle cell trait status? 
1 Yes 
2 No 
3 Don’t know 
4 Not applicable 
 
15) Do you have children? 
1 Yes 
2 No 
 
16) If you answered “Yes” to the previous question, do you know your child’s sickle cell trait 
status? 
1 Yes 
2 No 
3 Don’t know 
  
17) Do you know someone with sickle cell disease? 
1 Yes 
2 No 
3 Don’t know 
 
18) Do you know someone with sickle cell trait? 
1 Yes 
2 No 
3 Don’t know 
 
19) Do you know someone that was found to have sickle cell disease or trait by newborn 
screening? 
1 Yes 
2 No 
3 Don’t know 
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